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MODELING LIVER DISEASES USING HEPATIC CELL MICROARRAYS
ALEXANDER D. ROTH
ABSTRACT
Hepatocellular carcinoma (HCC) is an invasive and aggressive cancer of the liver that 
arises due to chronic cirrhosis. Research into understanding HCC has focused on two- 
dimensional (2D) and three-dimensional (3D) technologies to simulate the liver 
microenvironment and use animal models to model how HCC affects the rest of the body. 
3D hydrogel models are desired because they can mimic the transport behavior observed 
in vivo by structurally mimicking the extracellular matrix (ECM) without the ethical
concerns of animal models. However, hydrogels can be toxic to cells and require optimal 
procedures for appropriate handling. In this study, we created 3D models of liver diseases 
on high-throughput platforms. First, we optimized hydrogel attachment on micropillar 
chips by coating them with 0.01 w/v % PMA-OD in ethanol. Next, we optimized the 
protocol for encapsulation of viable Hep3B cells PuraMatrix peptide hydrogel, using a 
higher seeding density (6 * 106 cells/mL) and two post-print media washes. Then, we 
established the ability to transduce adenoviruses in situ in encapsulated cells and 
successfully demonstrated their dose-response behavior towards six compounds. In the 
second part, we scaled up to using the microwell chip platform and optimized the 
polymerization of oxidized methacrylated alginate (OMA) for Hep3B encapsulation. First, 
we plasma-treated microwell chips for 15 minutes at high RF to minimize bubbles. Then, 
we optimized micro-scale photopolymerization conditions at 45 % methacrylated OMA 
(OMA-45) and 2 w/v % OMA with 0.05 w/v % PI and reflective background under either 
low intensity, long duration (2.5 mW∕cm2 for 2 minutes) or high intensity, short duration 
(4.0 mW∕cm2, 30 seconds) light by testing cell viability at these conditions. Third, we used
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these OMA conditions to develop a high-throughput, real-time 3D cell migration assay on 
a newly engineered 384-pillar plate with sidewalls. We first developed a set of a protocols 
where out-of-focus cells are removed mean position of cells on a pillar are quantified. Next, 
we established a delay in growth factor release rate by co-encapsulating growth factors 
with OMA and methacrylated heparin sulfate sulfate (MH). Finally, we demonstrated 
collective cell migration occurred toward angiogenic growth factors at 6-10 μm∕day over 
two weeks. These results provide optimized chemistry between hydrogels and polystyrene, 
show effective hydrogel polymerization techniques for microscale tissue engineering, and 
yield several methods where scientists can model liver diseases in high-throughput.
viii
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CHAPTER I
BACKGROUND AND MOTIVATION
1.1. Introduction
Liver disease affects about 30 million (or 1 in 10) Americans alone annually [1].
Included in this statistic are non-alcoholic fatty liver disease (NAFLD), hepatitis, drug- 
induced liver injury (DILI), cirrhosis, and liver cancer [1]. In addition, as sanitary 
conditions in parts of the country and world are still poor, some of the incidents for these 
diseases are on the rise. Unlike other cancers, liver cancer rates are increasing in the US 
[1,2]. Because of the presence of liver disease throughout the US and world, it becomes 
necessary to develop adequate models to understand these illnesses and develop 
compounds to combat them.
In the case of liver cancer, the most prevalent cancer of the liver is hepatocellular 
carcinoma (HCC). HCC is generally triggered by chronic cirrhosis, which itself is caused 
by previous injuries to the liver, including hepatitis and the presence of various toxins [3]. 
About 65% of national liver cancer cases and 75% of global liver cancer cases are attributed 
to this illness [4]. The increases seen in HCC seem to be increasing in regions where
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individuals do not have access to good hygiene or clean food [1,5]. This illness is the most 
common cause of death of individuals affected with cirrhosis, with estimates varying 
between 10-30% of individuals with cirrhosis eventually developing HCC [5]. HCC 
generally is associated with poor prognosis in the late stage of diagnosis, as tumors are 
highly invasive and have a great potential to metastasize locally and globally [3]. While 
there are certain therapeutics that are available to treat the illness, the therapies for HCC 
are often tied to the mechanisms that trigger the illness itself and are again generally only 
effective during early staging of the disease [3,6].
Many of the current technologies for understanding HCC and creating compounds 
to combat the illness relies on screens for in vitro hepatocyte cultures as a method to weed 
out drug candidates before clinical trials [7]. Subsequent follow-up with animal models are 
used to reduce the possible drug failure [8—10]. For developing treatments and modeling 
the illness, emphasis is put on the evolution of the tumor, looking at angiogenesis and 
metastasis in particular [4,11]. Unfortunately, these screens often have poor predictive 
value in assessing hepatotoxicity potential [12]. HCC is an illness that often takes on 
characteristics based on the individual diagnosed, so the cells and technologies used in the 
models should account for this individual variation. Thus, the goal of scientists and doctors
is to better understand the mechanisms for liver diseases and focus on individualized
treatment methods.
For understanding liver disease (and HCC in particular), there is a shift of 
researchers to investigate three-dimensional (3D) in vitro cell cultures. Two-dimensional 
(2D) cultures often simplify the models significantly, and lack any extracellular matrix 
(ECM) components, which play a major role in understanding diseases [13]. Meanwhile,
2
in vivo models can give some insight into HCC, but ultimately animals are physiologically 
different enough from humans where they may not fully reflect all aspects of the disease 
[14]. Additionally, use of animals always contains some ethical issues and is expensive. 
3D in vitro models reconcile 2D in vitro models with in vivo models by replicating the
transport and mechanical properties seen in vivo while eliminating the need use of animal 
models [13]. Hydrogels are generally used in these 3D models, as they are ideal for 
replicating the tissue ECM properties [15].
In this introductory chapter, I will discuss the various mechanisms that contribute 
towards the development HCC. Next, I will highlight various models and techniques used 
in assessing HCC, focusing on distinguishing 2D in vitro cultures, 3D in vitro cultures, and 
in vivo models, and looking at particular techniques used in in vitro cultures. Finally, I will
look at materials used to in 3D in vitro studies, with particular emphasis on using various 
hydrogel materials to mimic the liver ECM.
1.2. Mechanisms of HCC Development
HCC is often caused by the development of a previous disease within the liver 
where the damaged tissue can eventually turn into cancer. Generally, these triggers can be 
manifested through exposure to liver toxins, such as alcohol/drugs, or viral insults, such as 
hepatitis. These diseases often trigger cirrhosis, which can eventually lead to HCC. 
However, other disease states, particularly ones that affect metabolism, may also trigger 
the development of HCC. The triggers and molecular mechanisms behind the development 
of HCC can be seen in Table 1. Additionally, because of the mutagenic nature associated 
with the main causes of HCC, affected individuals can contain multiple tumors, each with
3
distinct markers. In this section, we intend to discuss the various mechanisms that can lead
to HCC, focusing on the pathways that lead to HCC over other forms of liver cancer.
Table 1. Mechanisms Associated with HCC
Cause for HCC Affected Pathways
Hepatitis B Virus (HBV) P53, Wnt∕β-catenin, pRB, miR-122
Hepatitis C Virus (HCV) P53, Wnt∕β-catenin
Aflatoxins P53, miR-122
Alcohol-Induced Liver Injury Wnt∕β-catenin
Diabetes P53
1.2.1. Hepatitis B and C Viruses (HBV and HCV)
Hepatitis is the most common cause of HCC, with about 80 percent of HCC 
individuals had hepatitis preceding the onset of HCC [16,17]. Of these cases, hepatitis B 
virus (HBV) is the most common form of the illness that gives way to HCC, though cases 
of hepatitis C virus (HCV) cases have also been reported [17 - 19]. Chronic viral hepatitis 
is said to trigger HCC both directly and indirectly. Most of the indirect contribution to HCC 
is from the development of cirrhosis. While both forms of hepatitis can be manifested 
acutely and initially cured, both viruses can eventually lead to the chronic version of the 
disease [20]. and it is in this state where individuals become significantly more susceptible 
to both cirrhosis and HCC. In HBV, this is particularly troublesome as young children are 
more susceptible to developing chronic hepatitis than older individuals, and chronic HBV 
is not easily treated [16,17]. While both forms of the virus play roles in the development
of HCC, the mechanisms associated with each are different. HBV is a double-stranded
DNA virus that can integrate into the host genome and induce hepatocarcinogenesis via 
promoting cell proliferation, affecting DNA repair, and inducing inflammatory damage
4
[17,21]. HCV is a single stranded RNA virus that triggers host immune responses to cause 
inflammation but does not integrate with host DNA [22].
Both diseases can trigger HCC through multiple molecular mechanisms. Of all the 
causes for HCC, HBV has the potential to trigger more mechanisms than the others. These 
mechanisms include the Wnt∕β-catenin regulatory pathway [23], mutations on the p53 [24] 
or the tumor suppressor retinoblastoma (pRB) genes [5,23], complicating the mitogen- 
activated protein (MAP) kinase pathway [25], or affecting cytokine signaling [25,26]. 
Additionally, all of these pathways can act synergistically with expression of key cancer 
markers. The role of HBV in affecting these pathways involves the increased propensity 
for DNA methylation, histone modifications, and affecting the RNA interference
mechanisms that prevent the spread of cancer.
In the case of Wnt∕β-catenin, this pathway is important in regulating cell 
proliferation, cell differentiation, and cell migration [27,28]. This pathway can be
compromised via numerous mutations within the pathway, though most mutations that can 
progress to HCC directly affect β-catenin [23,27]. One thing to note about this pathway is 
that Wnt∕β-catenin dysregulation is not strictly linked to HCC, as other cancers have this 
pathway compromised, and individuals with type 2 diabetes may show an upregulation in
some isoforms of Wnt [3,28]. Both HBV and HCV have been linked with mutations to
Wnt∕β-catenin [17,23]. For β-catenin, mutations result in the increase of Wnt, linking to 
increased proliferation [28]. Mutations due to HBV and HCV in frizzled-7, a G protein 
coupled receptor (GPCR) involved in the Wnt pathways have also been found to be linked 
to increased susceptibility to HCC [29].
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In the case of the P53 pathway, often a single point mutation is enough to cause 
cancer, as inactivation of the tumor suppressor 53 (TP53) gene causing a decrease in 
apoptosis in the normal cell cycle, and general over-proliferation of cancer cells [24]. For 
HBV, this is due to a point mutation at the 249 codon [5,24]. However, mutations at codon
250 have been found to be in some cases of HCC as well [5].
In the pRB pathway, these set of genes act to suppress tumor formation by 
regulating the E2F family in cell cycle division and the activity of cyclin-dependent kinases 
(CDKs) [30]. pRB is reported to be tied to p53 as loss of pRB function results in loss of 
p53 function as well [23,30]. Mutations in the pRB pathway are specifically a mechanism 
of HBV only, with the pathways being most effected are inhibition of pl6 and 
overexpression of cyclin D1, which again promotes excessive cell growth [23].
MAP kinases play a significant role in cell proliferation, differentiation, adhesion,
and survival, as they receive signals from many of the tyrosine kinase receptors, including 
endothelial growth factor receptor (EGFR) and platelet-derived growth factor receptor 
(PDGFR) [25]. In the case of the MAP kinase pathway, both forms of hepatitis serve to 
upregulate this pathway, promoting cell proliferation and angiogenesis [3,25]. Unlike 
many of the other mechanisms for HCC discussed here, dysregulation of the MAP kinase 
pathway seems to be strictly a phenomenon related to hepatitis-induced HCC, though other 
cancers are also known to have levels of dysregulation associated with MAP kinase [23].
Mechanistically, issues related to the mutations in p53, pRB, and β-catenin are tied 
to the effect of DNA methylation by HBV or HCV, causing mutations in the various 
pathways leading to cancer [16,31]. The methylation sites result in the mutations described 
earlier, all of which result in uncontrolled cell growth [16]. Thus, the largest role of
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hepatitis in development of HCC stems from mutations in proteins that control the cell 
cycle.
This is not to say that the only mechanisms governing hepatitis-induced HCC rely 
to DNA methylation. Histones can be modified, which can also increase the likelihood of 
individuals developing HCC [31]. For example, HCV is known to increase the expression 
of protein phosphatase 2A (PP2A), which binds to protein arginine methyltransferase 1
(PRMT1) [17]. The result is a decrease in DNA desphosphorylation and histone 
methylation at sites which control hepatocellular carcinogenesis and DNA damage repair, 
though the latter is also important for viral replication [16]. For HBV, the generated viral 
protein HBx interacts with histone acetyltransferases in a way to promote their activity, 
which results in increased cellular replication [16].
Besides DNA methylation, HBV and HCV both have roles in affecting RNA 
interference and circulating miRNA, which deregulates the cell cycles. For HCV, miR- 
122, an antiproliferative microRNA can act to increase the odds of developing HCC as 
miR-122 serves to replication HCV [23,32]. On the other hand, this same microRNA acts 
against replication for HBV [32]. While generally suppressed levels of miR-122 have been 
shown to be indicative of HCC, that does not apply to individuals affected by HCV-induced 
hepatitis [32]. Other microRNAs that are associated with hepatitis include miR-141 which 
also serves to repression HBV replication, while miR-1 seems to increase HBV replication
[23,32].
1.2.2. Aflatoxins
Aflatoxins are a class of compounds characterized as secondary metabolites of the 
Aspergillus f!avus and Aspergillus paracitus molds [33]. Aflatoxins are generally found in
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contaminated harvest foods such as corn, rice, nuts and sorghum[33]. Aflatoxin metabolites 
are generally considered to be both poisonous and carcinogenic, with several versions of 
Aflatoxin considered to be strongly linked to the development of HCC [33].
One striking thing to note is how aflatoxins can also work synergistically with 
hepatitis B to manifest HCC. The incidence of HCC seems to be drastically increased when 
exposed to both aflatoxins and HBV [16,31]. Aflatoxins both stimulate the Wnt∕β-catenin 
as well as the p53 mechanisms of developing cancer [28,34]. For the p53 protein, it has 
been found that aflatoxin mutates the 249 codon, which limits the tumor suppressor gene
[35]. While this mutation is not absent in other cancers, aflatoxin’s metabolism in the liver
is cause for HCC to develop over other cancers [4,5].
Of all the potentially generated aflatoxins, the B1 variant (AFB 1) is the most potent, 
as nearly all animal tests have developed liver cancer once exposed to this toxin [24,35]. 
However, other variants of aflatoxin may also generate HCC. AFB1 may actually lead to 
HCC in utero and it has been shown that the most susceptible individuals to HCC are those 
exposed to HBV and aflatoxins at young ages [3,16]. The odds of an individual developing 
HCC in response to the presence of AFB1 can vary between 3:1 and 10:1 depending on the
health of the individual and other factors that can contribute to HCC [16,23].
The mechanisms for control of these various pathways involve DNA methylation 
and RNA interference. In the case of DNA methylation, the CYP450 generated metabolite, 
AFB 1-8,9, exo-epoxide adducts onto the guanine residues of DNA at the 249 codon in P53 
[35]. Aflatoxins may also inhibit the production of miR-122, which controls the replication 
of liver cells [32]. This makes miR-122 an interesting microRNA to exam for HCC, as
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promoting miR-122 levels could inhibit HCC due to aflatoxins, whereas it has the opposite 
effect of HCC induced by HCV [32].
1.2.3. Alcohol- and Drug-Induced Toxicity
Alcohol- and drug-induced toxicity can both contribute to the development of 
cirrhosis in the liver, and subsequently HCC. The major mechanism associated with 
toxicity developing into cancer involves the effects alcohol has on the Wnt∕β-catenin 
pathway [29,34]. Generally, β-catenin is the protein most likely to be mutated from 
alcohol- or drug-induced toxicity [16,36]. Additionally, it is believed that CYP2E1 
function is compromised via histone modifications in drug-induced toxicity [16]. This 
compromise in CYP2E1 function further inhibits drug metabolism and may affect
oxidative stress within the cell as well [37,38].
1.2.4. Other Concurrent Disease States
HCC has been shown to be caused by several other illnesses or conditions. An 
example of this is type II diabetes. As a metabolic disorder, diabetes mellitus has been 
shown to have some effects that may cause HCC, specifically inducing cirrhosis via 
affecting hormonal changes in the liver [39]. Obesity and hypertension has the effect to 
increase susceptibility to diabetes, but it may also cause HCC through separate mechanisms 
[11,39,40]. Additionally, hemochromatosis is another causative agent for HCC. The effect 
of iron-overload (hemochromatosis) has been shown to be associated with the p53 
mutations seen in aflatoxin-induced toxicity and HBV, targeting the methylation at the 249 
and 250 codons in p53 [31]. Hemochromatosis has several causes, including genetic 
mechanisms and previous disease states, including diabetes [41].
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1.2.5. Genetic and Environmental Factors
HCC does not need a pre-requisite of cirrhosis to occur, though most cases do 
follow that pattern. As HCC can occur with the presence of HBV in the system regardless 
of the concurrent conditions, any individuals that carry the virus are susceptible to 
developing cancer. African and Asian descent seem to be more at risk than other ethnic 
groups, though there is no gender predisposition to the disease [31]. Additionally, family 
history associated with HCC is shown to increase the susceptibility of an individual to 
develop the illness [16]. There are also several other carcinogens that may cause HCC. 
Generally, the carcinogens that promote cancer do so via mutations on the Ras family of 
proteins, which ultimately has the impact of increase MAP kinase protein signaling, 
specifically targeting MAP kinase kinase (MEK) 1 and 2 [25]. This has the impact of
decreasing apoptosis and increasing proliferation [25].
1.2.6. Diagnostic Measures
There are several biomarkers present that are commonly used for the detection of 
HCC. Specific microRNAs are generally as an indicator for the presence of this illness in 
individuals. However, there are other prognostic indicators. Testing for the levels of alpha- 
fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP) are generally recommended 
by physicians before further examination of the tumor [42]. AFP is normally found in
elevated levels in pregnant women, playing a fetal analog or pre-cursor to serum albumin; 
but if it is detected at elevated levels, AFP can otherwise indicate the presence of benign 
or malignant germ cell tumors or other liver cancers in addition to HCC [19,43]. DCP is a 
variant of the coagulation protein prothrombin though it may also be detected in individuals 
with vitamin K deficiency [42]. Genetic profiling can also be used to diagnose HCC, as
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quantifying the levels of affected microRNAs or specific gene panels can be indicative of 
a positive diagnosis. Genetic panels can predict the illness over 90% of the time [42,44]. 
The presence of interleukins 2 and 15 (IL-2 and IL-15 respectively), regulatory T cells 
(Tregs), and tumor-associated macrophages (TAMs) are also positive diagnostic markers 
for HBV-induced HCC [45]. Additionally, CTs and MRIs are also used to observe the 
tumor and confirm diagnosis with the blood tests [36].
1.3 Models and Techniques for Understanding HCC
In order to better understand HCC, in vitro and in vivo models have been generated 
for examining the illness. Most important are the presence of appropriate cell types and the 
recapitulation of the tumor architecture. The tumor physiology is characterized by having 
a diverse set of cell types, including cancer-associated fibroblasts, cells promoting 
angiogenesis, and cancer immune cells [3]. In addition, tumor vasculature is more 
heterogeneous and less dense than healthy tissue, as blood flow and oxygen and nutrient 
transport is limited within the tumor [46]. Predictive tumor models are designed to mimic 
these features and understand the mechanisms behind cell proliferation and metastasis. In 
this section, we look to discuss the various models used to study HCC, and evaluate how 
they perform in terms of accurate representations of the illness.
1.3.1. 2D Cancer Migration Models
Because of the complexity of HCC, 2D cancer models focus on a limited number 
of variables when examining the illness. 2D models are best used when observing 
proliferation and some migration studies, as they can give insight into the effects of some 
potential chemoattractants. One such example uses wound healing assays, where artificial
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wounds are introduced into cellular monolayers, and the cancer cells migration in response 
to close the gap [47 49]. Similar models, such as the cell exclusion zone assay [50] or the 
fence assay [51], also create barriers in a monolayer of cells through which the cells must 
migrate. The cell exclusion zone assay utilizes seeding on two different sides of a removal 
barrier and watch cells close the gap, while a fence assay utilizes cells seeded inside of a 
removal insert and spread after the insert is removed. All of these migration assays are mid- 
throughput and can be used for real-time monitoring of migration. While there is ease 
associated with quantifying this type of behavior and chemical gradients can be induced, 
the 2D environment is still limited regarding nutrient transport and the interactions that can
occur between different cells [47,52].
Another method that can be used is the Boyden chamber model. Here, cells are 
seeded in a removable well with a porous membrane on the bottom surface while 
submerged in a second well containing media and any chemoattractants/repellants [47,48]. 
The pores are small enough to make sure cells simple do not fall through the membrane 
without a chemical gradient driving the movement, meaning cells will only pass through if 
the chemoattractant is strong enough [53,54]. If the pore is sufficiently small, cells will not 
pass through but instead adhere strongly to the bottom part of the top chamber. Both of the 
wound healing assay and the Boyden chamber have some moderate-throughput potential 
to test multiple factors affecting HCC metastasis. However, the design of the Boyden 
chamber makes it a better end-point assay for cancer cell migration, whereas other 2D 
migration assays are kinetic [47].
To overcome some of the limitations of 2D cell migration, scientists have 
introduced microfluidic devices. Here, capillary flow can assist with some movement of
12
the cell, while chemoattractants or repellents can be added near the periphery of the 
capillary, allowing scientists to measure how much cells may deflect in movement in 
response to these cues [55,56]. Microfluidic devices provide some shear effects seen in 
vivo and are suitable for real-time tracking of cell movement, but they are relatively 
expensive to develop and their throughput is lower than some of the other 2D migration
models [55].
1.3.2. Spheroid Models
In generating spheroids, scientists, clinicians, and researchers can observe a round 
3D structure that is similar in architecture to normal tumor models. Generally, spheroids 
strictly consist of cells, though they occasionally may include ECM components, or they 
may secrete some ECM components themselves [57]. While spheroids do not have to be 
homogenous in cell composition, spheroids do have uniform cell seeding density when 
initially developed, which is not always the case when tumors are observed [58]. 
Additionally, because most spheroids do lack the ECM components, a large part of the 
interaction between cancer cells and their microenvironment is missing, with cell-cell 
interactions dominating the signaling occurring in these models [47]. It is also difficult to 
generate spheroids based on size, and in the case of co-culture spheroids, it is sometimes 
hard to predict how various cell types are arranged within the spheroid [59,60]. However, 
much like actual tumors, spheroid cultures do maintain the aspects of the cell density 
arrangement; namely, cells in the center of the spheroid tend to be both hypoxic, nutrient 
deficient, and necrotic, whereas cells closer to the spheroid periphery are more proliferative 
and have better exposure to nutrients and oxygen [47,61].
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There are several methods in which to create spheroid structures. Using hanging 
droplets within plates is one way to generate spheroids, as gravity forces cells to aggregate 
near the bottom of the droplet [62]. Depending on the size of the plate, several spheroids 
can be generated, with homogenous size distributions [63]. However, because these 
spheroids are generated in media or PBS, many of the architectural supports associated 
with 3D matrices and the ECM have been eliminated, unless cells are able to generate these 
components themselves [63,64]. Additionally, for more thorough assays, the spheroids 
need to be transferred to a different plate, which is very labor intensive and more 
susceptible to human error than other methods for generating spheroids [47]. Finally, the 
volumes associated with hanging droplets are quite low, making the droplet more 
susceptible to evaporation, which has a direct impact on the osmolarity of the solution, and 
hence, the viability of the cells in the spheroid [62].
Another common method for spheroid generation are using ultralow attachment 
plates. Seeding cells on non-adherent substrates such as agar can force cells to interact with 
each other and form spheroids [65]. Like the hanging droplet method, ultralow attachment 
plates can produce vast quantities of spheroids [66]. Spheroids generated this way are also 
easier for transfer than ones in hanging droplets, making them somewhat less labor 
intensive [65,66]. However, the spheroid suspensions generated this way tend to be 
heterogeneous in size, and they too suffer from issues where a lack of ECM components 
can make holding together the spheroid more difficult [65].
While hanging droplet and ultra-low attachment plates can generate large amounts 
of spheroids, addition of hydrogels or ECM components can strengthen the spheroid via 
promoting cell-cell and cell-ECM interactions typically seen in vivo. Here, cells are either
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seeded on top of or within hydrogels, and over time, cells will naturally aggregate if 
incubated and maintained with cell culture media [49]. Generation of spheroids this way 
relies on the mechanisms of the cells to aggregate and bond to the surrounding structures 
than reactions to physical stimuli [47,67]. Spheroids generated this way tend to have 
characteristics more similar to in vivo studies and these spheroids can also be generated in 
high-throughput [67]. Like ultra-low attachment plates, spheroids generated this way are 
typically heterogenous in size and structure and using hydrogels or ECM components can 
occasionally cause problems when staining or imaging cells [47,65].
Generation of spheroids can be subsequently used in either 2D or 3D migration 
assays. Much like the fence assay, spread of cells away from the spheroid can be measured 
in real time to characterize the cells [68]. Additionally, spheroids can be embedded or 
seeded on top of hydrogel matrices and directed to migrate in response to certain cues [49]. 
The problem with using spheroids this way is that while behavior of the spheroid can be 
tracked easily, individual cell movement is harder to track as compared to many of the 2D
models [68].
1.3.3. Sandwich Culture Assays
In sandwich culture, cells are seeded between two hydrogel layers, in which the 
hydrogel layers contain various chemoattractants or chemorepellants [69]. The cells 
respond to the chemoattractants or repellants either through increased growth or through 
migration in response to the signal [69,70]. Like spheroids, cells in sandwich culture exist
in 3D, so the mechanical and chemical interactions are closer to in vivo cultures. Like
spheroids, imaging can be difficult, although this is generally less of a problem as 
individual cells are easier to track once outside the spheroid [47,71]. Some of the cell-cell
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interactions are not completely reflected on initial seeding, as it takes time for the cells to 
organize themselves into 3D structures [70]. However, spheroids can also be seeded in 
sandwiches, though individual cell tracking is still difficult with sandwich spheroids [72]. 
Another drawback is that because the cells are seeded within hydrogels, there are other- 
potential barriers to delivery of nutrients and oxygen to the sandwiched cells, which can 
make sustained culture of sandwiched cells somewhat more difficult as compared to other 
HCC mimics [73]. Like the other cultures, there are relatively few limits to cells sourced 
for sandwich culture, which means explants and heterogenous tissues can be seeded [74].
1.3.4. Co-Culture Systems
Liver co-culture systems provide the advantage of giving a more complete profile 
of liver behavior in the presence of drugs. While the liver is primarily composed of 
hepatocytes, there are other cells present, including several different kinds of lymphocytes,
sinusoidal endothelial cells, and stellate cells [75]. In the case of cancer, co-cultures can
consist of any combination of the cancers cells with fibroblasts, immune cells, stem cells, 
and potentially other cell types present in the affected organ, including normal functioning 
cells (i.e., co-cultures of hepatocytes and HCC cells) [76,77]. In addition, the liver is 
organized based on proximity to blood vessels. Cells closer the portal vein are more 
involved in oxidative metabolism, β-oxidation of fatty acids, ureagenesis, and 
gluconeogensis, whereas cells further from major blood vessels are involved in 
biotransformation of drugs, glutamine synthesis, lipid synthesis, and glycolysis [78]. As a 
result, development of models for understanding liver disease is more complex While co- 
culture systems tend to be more complex than some of the other HCC systems discussed, 
they generally do incorporate 3D behavior and better recapitulation of the tumor
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microenvironment than other systems [79]. Additionally, co-cultures can be incorporated 
into some of the previously mentioned technologies, including 2D migration assays [80] 
and spheroid cultures [61].
Most HCC co-cultures focus on the use of HCC along with fibroblasts and immune 
cells, as these cells are generally necessary to best model the in vivo responses. While 
utilizing HCC is obvious, fibroblasts are important for secretion of ECM proteins such as 
laminin and fibronectin [81]. Laminin is especially important, as this component is 
generally present in greater quantities in HCC than in healthy livers [6,46,82]. Generally,
fibroblasts can be incorporated in 3D suspensions with HCC cells, regardless of the 
presence or absence of hydrogels [79]. Additionally, 2D co-cultures can also be achieved. 
By seeding fibroblasts first, several ECM components can be secreted, which allows for 
easy adherence of HCC cells onto various surfaces and can promote cell-ECM interactions 
that are normally absent in 2D culture [83].
Several kinds of immune cells have interactions with HCC and the ECM in ways 
that involve inflammation responses that can subsequently lead either the liver’s tolerance 
or adaptive immunity to certain signals. While KCs are native to the liver, other cells, 
including CD8+ T cells and regulatory T cells (Tregs) both play a role in the progression of 
HCC [45]. The relative presence of tumor-associated macrophages (TAMs) is also an 
indicator of the prognosis of potential outcomes for an individual affected with HCC [84]. 
HCC co-cultures with lymphocytes generally have the lymphocytes in suspension, 
responding to signals of static HCC cells, as the lymphocytes will act on the tumor [84].
Disadvantages of coculture platforms involve the complexity of the scaffolds to 
accurately mimic the in vivo liver environment, as well miniaturization being limited due
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to the number of cells needed to create a full model of a tumor. The assay miniaturization 
is of particular importance, as this also impacts scalability and cost. Even integrating all 
cell types on a 96 well-plate platform is challenging because decreasing the number of cells 
limits interactions observed between different cell types. Thus, size of culture optimization 
should be considered when designing small scale liver tissues for toxicity testing.
1.3.5. In vivo Models
Animal models make up a large fraction of the studies used in scientific literature
for HCC [85]. While in vitro models can use excised tumors or immortalized cell lines such
as Hep3B, HepG2, or Huh7 cells, rat and mouse models make up most organisms used for 
in vivo studies [86]. Cells and the animals they are implanted into can vary significantly 
depending on the mechanism of HCC development studied. Many in vivo models use 
xenografts of HCC tumors by injecting HCC cells subcutaneously [84]. Generally, this 
procedure is less invasive and easier to monitor than orthotopic models, where HCC cells 
are surgically implanted within the liver. However, the orthotopic model is considered to 
be more accurate as the cells are residing at the site where the illness normally starts, so 
growth and metastasis of the tumor is more adequately reflected [85].
Scientists have successfully shown the treatment of various HCCs developed in 
vivo using the orthotopic model. The aforementioned Hep3B, HepG2, and Huh7 cell lines
have all been implanted into mice, with cell growth demonstrated to have occurred in these
various models, and treatment was found to be affected in some of them [85]. The
drawback to using in vivo models is that even with humanized mice, several functions 
cannot be completely replicated in a different species, and the size of mice also limits how 
large tumors can grow within the organism [60], making it much easier to treat the illness
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here than clinically. Additionally, because of the in vivo implementation of tumors, the 
imaging of the tumors is generally done with CT or MRI, which are more expensive and 
time consuming than the methods used to visualize in vitro models [4,11].
1.4. Materials to Mimic the 3D Liver Architecture
As discussed earlier, the best methods for understanding the behavior of the liver 
or other tissues in vitro rely on the development of materials that allow for cells to organize 
themselves into their native architecture. Most often, this relies on hydrogels or similar 
materials to recapitulation the 3D architecture seen in the tissues. Hydrogels are most 
commonly used as their high degree of water content allows the hydrogel to reflect some 
of the mechanical properties seen in tissues [87]. Here we discuss the various kinds of 
hydrogels as well as other 3D platforms that have been used to characterize HCC.
1.4.1. Alginate
Alginate is an anionic polysaccharide hydrogel derived from algae [88]. It forms a 
gel in the presence of strong divalent cations, which serve to crosslink the negatively 
charged hydroxyl groups [89]. Alginate was originally used medically to encapsulate 
pancreatic islet cells as a potential to treat patients with diabetes [89]. Since then, its use 
has expanded to other cell lines, including the study of hepatic cells [60]. The use of 
alginate hydrogels is popular as alginate is generally structurally stable and the 
polymerization mechanisms are relatively nontoxic [90]. However, because of it being 
derived from plant matter, alginate lacks many of the necessary functional groups for cell 
adherence [89]. Subsequently, this limits the amount of manipulation cells can have on 
their microenvironment and slows down any changes should they come.
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In order to bypass these issues, alginate can be modified with functional groups. 
Integrin-binding sites at RGD residues can be added within the hydrogel structure, which 
allows for better cell adherence [91]. Other peptide binding sequences have also been 
conjugated onto alginate to promote cell adhesion [91]. Additionally, co-encapsulation 
with mammalian derived hydrogels such as Matrigel can also improve cell-ECM 
interactions [92]. Alginate is generally best employed when emphasizing structure stability 
of the hydrogel with some level of co-encapsulation with somewhat more biocompatible 
polymers, such as modified polyethylene glycol (PEG), polycaprolactone (PCL), or 
polylactic acid (PLA) [91].
1.4.2. Collagen
Collagen is a structural protein found in many organs in the body, including the 
liver. Most of the liver’s structural protein mass consists of collagen I, though there is a 
noticeable amount of collagen IV in the liver as well [52]. Collagen can also be used as a 
biomimetic hydrogel via temperature-based polymerization [93 ]. The advantage to using 
collagen is that since it is a native protein, hepatocyte and hepatoma cells have favorable 
interactions with the protein, making it a suitable host for cell encapsulation and migration 
[72]. Collagen’s natural compatibility with liver cells has made it so that liver models 
mimic many of the key liver functions, including drug and glucose metabolism [94]. The 
disadvantage to using collagen as a hydrogel is because it is a native liver protein, it is more 
susceptible to degradation and ECM remodeling, which may or may not be desired in a 
given experiment [13]. Additionally, because of the temperature-controlled polymerization 
mechanism, cells must be kept at lower temperatures to prevent premature gelation, and 
this temperature cycling can have a deleterious effect on cells [95].
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1.4.3. Gelatin
Gelatin is another biologically derived hydrogel, composed of peptides and proteins 
following the hydrolysis of collagen in the connective tissue, skin, and bones of 
mammalian organisms [96]. Gelatin can be polymerized in a variety of different ways, 
including natural polymerization in sufficient concentrations in water [97]. However, 
addition of crosslinking agents or enzymatic polymerization using transaminases can 
improve hydrogel stability [98]. Because of the fact that gelatin is biologically derived and 
has multiple methods for polymerization, it is a popular hydrogel for cell encapsulation 
purposes. However, addition of a crosslinker always increases the chance for cytotoxicity 
and the use of enzymatic catalysis for polymerization often results in inconsistent 
crosslinking densities, which makes the hydrogel less tunable for desired properties [47].
Gelatin naturally contains many of the important functional groups necessary for 
cell adhesion to the ECM. While gelatin is a popular hydrogel for several different kinds 
of tissue engineering, methacroyl gelatin (GelMA) has seen increasing popularity for 
wound healing purposes [98]. Here, GelMA is modified with methacrylate groups, which 
allows for a photo-polymerization based mechanism of the hydrogel [99]. This serves to 
increase the stiffness of the hydrogel relative to gelatin and makes it somewhat more 
resistant to degradation while still allowing cells the ability to reshape the surrounding 
tissue [98]. However, the process for photopolymerization is also quite toxic, as radicals 
generated from the polymerization can generate ROS and cause oxidative damage [98,99]. 
1.4.4 Hyaluronic Acid
Hyaluronic acid (HA) is a glycosaminoglycan (GAG), a long polysaccharide chain 
containing a urea group in every other saccharide molecule [100]. It is found in connective
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and epithelial tissue throughout the body and serves as a structural molecule to anchor cells 
while also having numerous regulatory processes [100]. HA is degraded relatively easily, 
which makes it a suitable material for both structural stability and ECM remodeling 
[15,101]. The mechanism by which hyaluronic acid forms gels can depend on the 
modifications associated with the material [100,101]. This can be enzymatic 
polymerization, photopolymerization, or polymerization using a cross-linking agent like
glutaraldehyde. The drawbacks to using HA are, much like gelatin, related to the agents 
used for crosslinking more than compatibility issues with the hydrogel itself [100,102].
1.4.5. Fibrin
Fibrin is the natural product polymer formed during scar tissue formation when 
fibrinogen is polymerized by thrombin [96,103]. The same mechanism governs the
formation of this hydrogel. Because it is a naturally occurring hydrogel, the toxicity 
associated with fibrin is quite low, and it is easily compatible with multiple cell types [96]. 
The drawback with using fibrin is that it is arguably the most susceptible to degradation,
as cells have a natural mechanism to restructure the ECM around scar tissue [90].
Additionally, this hydrogel generally has weaker mechanical properties compared to other 
hydrogels, so it is best used in conjunction with other degradation-resistant hydrogels such 
as alginate or hyaluronic acid [104,105]. However, the ability for fibrin to be degraded and 
be biocompatible means cells have better abilities to reshape their microenvironment.
1.4.6. Peptide-Functionalized Materials
Cells can adhere to ECM proteins as a result of interactions between integrins and 
certain peptide motifs such as RGD sequences. While synthetic hydrogels have been used 
to serve as mimics of the in vivo ECM, biocompatibility issues pose a problem which
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affects cell viability, function, and the ability of the cell to reshape its environment. 
Modification of hydrogels to include the integrin-binding peptides can promote cell- 
adhesion and improve biocompatibility of many synthetic hydrogels [106]. As cells are 
adherent, they are also more likely to move and manipulate the environment in reaction to
various chemical cues.
Generally, the hydrogels that are peptide-functionalized include many of the 
polysaccharide-based hydrogels, including alginate, chitosan, and hyaluronic acid [107— 
109]. Fibrin, collagen, and derivatives of these hydrogels already have the functional sites 
necessary for cell adhesion. Additionally, several synthetic hydrogels are commercially 
available that contain peptide groups, including PuraMatrix, PGMatrix, and HydroMatrix 
[110]. Because of the use of peptide linkages, these matrices are more suited for soft-tissue 
models [110,111]. A disadvantage of using these hydrogels are the expenses associated 
with them [110]. While the other hydrogels can be obtained in bulk from natural sources, 
peptide hydrogels must be synthesized, and peptide functionalization of natural hydrogels 
incurs its own preparation costs that may be more expensive than other hydrogel
modifications.
1.4.7. Nanofibers
An alternative to using hydrogels or derived liver matrices for in vitro 3D cell
culture are nanofibers. Nanofibers are fibers with nanometer-sized diameter that may be 
synthesized from a variety of different functional materials, including polyvinyl alcohol 
(PVA), PCL, PLL, PEG, and others [112]. They are generally synthesized via
electrospinning or phase separation process. In both cases, fiber alignment can be random, 
or controlled depending on the application [113,114]. After fibers are synthesized, cells are
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seeded. While the fibers offer some of the structure advantages of hydrogels (namely, 
increased stiffness and homogeneity of structure), nanofibers are not necessarily degraded 
by the cells, which gives the cell little ability to shift the environment [115]. Fibers can be 
used in migration studies, particularly if they are aligned to promote directional movement
[116].
1.5. Significance and Aims of the Research
The goal of this study is to have a better understanding of various liver disease 
states by utilizing a comprehensive high-throughput platform. Initially, we intended to use 
this platform for analyzing the potential for an individual to be susceptible to drug induced 
liver injury (DILI). DILI refers to injuries from ADRs because of individual, non-dose-
dependent responses. The advantage of our system includes rapid generation of 
miniaturized liver tissue constructs in microarrays via bioprinting technology, which 
allows us to examine combinations of microenvironment conditions. Our system is capable 
of printing hydrogels onto small, microscope slide-sized micropillar/microwell chips
containing 532 individual tests, or onto larger 384-pillar plates that are paired with standard 
384-well plates. The microwell chip can be used as a vessel for a layer-by-layer printing 
approach for 3D cell culture. Alternatively, the microwell chip can contain media and be 
paired with the micropillar chip, which is used for culturing a small, but sizeable number 
of cells for individual assays. The 384-pillar plate with sidewalls offers a slightly larger 
scale test that pairs with a known, readily available platform, and the sidewalls on the 
platform can hold hydrogels in place as the plate changes between various media 
compositions in the 384 well plate. The basis of our work relies on the hypotheses that 1) 
three-dimensional (3D) hydrogel layers are a better mimic of the in vivo liver
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microenvironment than two-dimensional (2D) platforms or other 3D platforms, 2) layer-
by-layer printing of hydrogels can be used to create organized liver tissue organoids in 
vitro, and 3) liver cancer cells will migration through hydrogels in vitro towards potential
metastatic cues and that this migration can be quantified in 3D.
The most significant outcome of this study is the creation of miniaturized liver 
tissue constructs and an ability to accurately measure and quantify cell migration in situ. 
These results can be used to better understand metastasis, or any kind of cell migration to 
various chemical cues. Another potential outcome is the ability to control for genetic 
expression of key enzymes affected during certain liver disease states. While not all 
contributing factors towards DILI or liver cancer will be examined in this study, our 
platform can be used for future studies to examine those other factors.
Specific Aims: The specific aims (and subsequent chapter themes) are:
Aim 1: Encapsulate hepatic cells in hydrogels that can be used for high-throughput
drug screening and in situ adenoviral transduction. The goal of this work was to 
develop a platform where we could encapsulate Hep3B human hepatoma cell line in 
PuraMatrix that could provide the cells with a stable and non-toxic architecture while also 
being suitable for genetic modification using adenoviral transduction.
Aim 2: Optimize hepatic cell encapsulation conditions in a photopolymerizable
hydrogel for creating layered cell structures. While PuraMatrix is a suitable platform 
for adenoviral gene transduction, the protocol for cell printing and the hydrogel itself was 
toxic due to the removal of salts from printing solutions and acidity of PuraMatrix. 
Additionally, the micropillar plate platform was unsuitable for long-term multicellular
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tissue culture as the low volume of cells used during the print may not be enough for the 
encapsulated cells to develop an appropriate liver microenvironment seen in disease states. 
Thus, we decided to try new hydrogels for Hep3B cell encapsulation and find a more 
suitable platform for 3D cell culture. Here, we optimized the use of photopolymerizable 
oxymethacrylated alginate (OMA) for cell encapsulation for 3D cell culture in the 
microwell chip. OMA polymerizes in the presence of photoinitiator (PI) 2-Hydroxy-4'-(2-
hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959) while exposed to near-UV light. 
Our desire to use this material is for layer-by-layer printing; a photopolymerizable hydrogel 
gives us more control over when we decide to initiate polymerization in situ.
Aim 3: Simulate migration of liver cancer cells in 3D and quantify their migration in 
situ in high throughput. After optimizing photopolymerizable OMA for use, we simulate 
hepatocellular carcinoma (HCC) by printing Hep3B cells in OMA and quantify Hep3B cell
migration in 3D in the presence of various chemoattractants. Our group designed a 384- 
pillar plate with sidewalls paired with a 384-well plate using the same assay protocol. This 
new modification allows for better nutrient transport to all cells while being usable for 
combinatorial studies. First, we tested the effects of leaching of various growth factors and 
ECM proteins known to exist in the microenvironment of HCC by encapsulating the 
compounds with OMA in the presence and absence of heparin sulfate. Next, we 
demonstrated the ability to image cells in situ by transducing Hep3B cells with lentiviruses 
containing fluorescent proteins. Finally, transduced cells migrated in 3D because of 
exposure to various growth factors and ECM proteins. This migration was quantified using 
a set of macros developed for ImageJ that filter out out-of-focus cells, quantify the intensity 
of the filtered cell images, then calculates the mean position of the cells on the pillar.
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CHAPTER II
POLYMER COATING ON A MICROPILLAR CHIP FOR ROBUST
ATTACHMENT OF PURAMATRIX PEPTIDE HYDROGEL FOR 3D HEPATIC
CELL CULTURE
2.1. Introduction
Recent advances in three-dimensional (3D) cell culture technologies demonstrate 
clear advantages over traditional two-dimensional (2D) cell cultures, which include cells 
in biomimetic 3D microenvironments, promoting cell-cell and cell-extracellular matrix
(ECM) interactions that are critical for many biological and physiological processes 
[78,117,118]. The transport of drugs and nutrients is vastly different between the two 
systems, resulting in some 2D cell culture systems that cannot accurately predict certain 
biological disease states [78,119,120]. Mimicking 3D microenvironments are crucial in
both modeling disease states with cell models and understanding how to treat these diseases
One way to mimic in vivo 3D cell structure is to use hydrogels as a scaffold for cell 
growth. Hydrogels can provide a mechanical and biochemical environment that is similar
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to in vivo cell-ECM interactions, promoting the formation of tissue-like structures [90]. 
Hydrogels might be biologically derived, completely synthetic, or somewhere in between 
the synthetic and biological extremes [87,96,102,121-123]. Hydrogels can be polymerized
in the presence of divalent ions (e.g., alginate), UV-light (methacrylated collagen), 
enzymes (fibrinogen), or changes in temperature and pH (Matrigel), all of which depend 
on the hydrogel being studied [124-127]. Many of the synthetic hydrogels use biological 
motifs found in the ECM to improve cell attachment, and thus, providing biocompatibility 
[96,121,123]. Nonetheless, large scale 3D-tissue culture in hydrogels is challenging for
high-throughput screening (HTS) of potential drug candidates due to cumbersome steps 
necessary for dispensing viscous hydrogels and changing growth media over time, 
difficulty in imaging 3D-cultured cells, limited diffusion of nutrients within a 3D construct,
and high costs of primary human cells.
To alleviate these issues, miniaturized 3D cell cultures in hydrogels have been 
investigated, including cellular microarrays [128- 130]. While microarray technologies
have existed for molecular detection, including nucleic acids [131-133] and proteins 
[134,135], cellular microarrays are relatively recent development [90,136]. Cells
suspended in hydrogels may be micropatterned onto various surfaces using 
photolithography [137-140], or they may be printed in mini-arrays on functionalized glass
slides and plastic chips using automatic liquid dispensation systems [129,130,136,141 ]. 
These bioprinted cells were cultured in 3D and subsequently exposed to various 
compounds and viruses for toxicity assessment [129,130,136]. For example, Kwon et. al.
and Lee et. al. have developed a micropillar/microwell chip system that can support 
miniaturized 3D cultures with 50 - 400 cells seeded on each micropillar for recapitulating
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certain in vivo behaviors and is small enough to provide sufficient nutrient transport to cells 
within hydrogels (Figure 1) [136,142,143]. Thus, the chip platform is great for assay
miniaturization, as biological assays can be performed at one hundredth the volume of the 
same test performed on a 96-well plate. Additionally, when using the microwell chip as a 
vessel for containing media and other reagents, it is easier to change growth media and 
modify culture conditions without disturbing the cells as is the case for well plate 
experiments.
PuraMatrix droplet 
containing Hep3B cells
Compounds
Figure 1. Schematic representation of the micropillar and microwell chip platform for use 
in Hep3B cell encapsulation in PuraMatrix and compound toxicity assessment.
In the present study, PuraMatrix was explored as a hydrogel matrix for cell 
encapsulation on the micropillar chip. PuraMatrix is a peptide hydrogel containing a 
repeating sequence of arginine-alanine-aspartic acid-alanine (RADA) residues. These 
residues are analogous to the arginine-glycine-aspartic acid (RGD) sequence found in the 
tissue ECM that cell-surface integrins bind to, which makes PuraMatrix an ideal synthetic
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hydrogel for recapitulating in vivo cell-ECM interactions. While the study of PuraMatrix
has been performed for use in neural cell lineages [111,144] and tissue vascularization 
[103], limited work has been performed with hepatic cell lineages for HTS of potential 
drug candidates. However, PuraMatrix has been used for tumor spheroid models in 
conjunction with other hydrogels [145], and it has been shown that PuraMatrix is positively 
associated with albumin synthesis compared to other hydrogels, a function specific to 
hepatocytes [115]. Additionally, PuraMatrix has been shown to improve the formation of 
bile canaliculi in 3D [146]. Another major motivation for using PuraMatrix is its peptide
structure, which makes encapsulated cells amenable to viral transduction. This is in 
contrast with alginate, which has been used successfully in the culture of hepatic cell lines 
on the micropillar/microwell chip in the past, but has not been successfully used for
adenoviral transduction [ 136,143].
The goal of the research was to establish the use of PuraMatrix as a viable hydrogel 
for hepatic cell culture in 3D on the micropillar chip and prove that control of protein 
expression via adenoviral transduction into hepatic cells is possible while cells are 
encapsulated in hydrogels. Surface chemistry was optimized with several amphiphilic 
polymers with maleic anhydride groups for robust spot attachment, and gelation 
mechanisms were compared by printing with various salts and ionic polymers. With 
optimized 3D cell culture conditions, Hep3B cells encapsulated in PuraMatrix and cultured 
in 3D were exposed to recombinant adenoviruses to demonstrate on-chip gene transduction. 
Finally, 3D-cultured Hep3B cells in PuraMatrix on the chip cells were tested with several 
model compounds at various concentrations, and IC50 values obtained were compared with 
literature in vivo and in vitro toxicity values.
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2.2. Materials and Methods
2.2.1. Materials
Polyethylene oxide-maleic anhydride copolymers including ACM 1510, ADM 1510, 
AEM1510, AKM0530, and AKM1510 used for surface coating of the micropillar chip 
were kindly supplied from Nippon Oil and Fat Co., Japan. Poly(maleic anhydride-alt-l-
octadecene) (PMA-OD) and poly(maleic anhydride-alt-1-tetradecene) (PMA-TD) were 
purchased from Sigma Aldrich. The chemical formulae of the compounds are given in 
Figure 2. PuraMatrix peptide hydrogel was obtained from BD Biosciences. Hep3B human 
hepatoma cell line and human embryonic kidney (HEK293) cells were obtained from
ATCC (catalog nos. HB-8064 and CRE-1573 respectively), as were all cell culture 
ingredients, including growth media, sera, and antibiotics. The micropillar and micro well 
chips were manufactured by MBD Korea (Suwon, South Korea). Model compounds 
including acetaminophen, lovastatin, rotenone, tamoxifen, menadione, and sodium citrate 
were obtained from Sigma Aldrich. Sucrose, Dulbecco’s phosphate-buffered saline (D- 
PBS), sodium alginate, BaCl2, NaCl, and CaCl2 were also obtained from Sigma Aldrich. 
Calcein AM and ethidium homodimer were obtained from ThermoFisher. 96-well plates 
and 0.01% (w∕v) poly-L-lysine (PLL) solution were obtained from ThermoFisher.
2.2.2. Cell culture
Hep3B cells at the passage number between 15-50 were cultured in T75 flasks with 
Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% (v∕v) fetal
bovine serum (FBS). For chip experiments, Hep3B cells were cultured in complete RPMI
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containing 10% (v∕v) FBS, 1% (v∕v) penicillin and streptomycin (P∕S), and 0.1% (v∕v) 
gentamycin. HEK293 cells at the passage number between 2-10 were cultured in eagle’s 
minimum essential medium (EMEM) with 10% (v∕v) FBS for the amplification of
recombinant adenoviruses and the measurement of viral titers.
Figure 2. Chemical structures of amphiphilic polymers used to coat the micropillar chip: 
(A) Polyethylene oxide-maleic anhydride copolymers including ACM 1510, ADM1510, 
AEM1510, AKM0530, and AKM1510 which are the names designated by the company 
manufacturing the polymers. (B) Poly(maleic anhydride-alt-1-octadecene) (PMA-OD) and 
poly(maleic anhydride-alt-l-tetradecene) (PMA-TD).
2.2.3. Microwell chip preparation
For all experiments, a 950 nL/microwell printing protocol was used to print growth 
media into the microwell chips. The microwell chips were always warmed 30-60 min in
humidified, air-tight chambers to 37oC in a Heracell 150i CO2 incubator from
ThermoFisher before stamping printed cell cultures. All printing protocols were performed
while keeping the chip deck at 7oC to avoid water evaporation.
2.2.4. Optimization of surface coating of the micropillar chip
Ethanol was used to dissolve all the polymers used for surface coating. All stock 
solutions contained 1% (w∕v) polymer. Hydrophobicity of the polymers was tested by
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attempting to dissolve 1% (w∕v) polymers in water under continuous stir for 24 h. In 
addition, 0.1% (w∕v) polymer solutions in ethanol were prepared for surface coating of the 
micropillar chips. A shallow-well staining plate was filled with 2 mL of 0.1% (w∕v) 
polymer solution in ethanol per chip, and then the micropillars briefly submerged in the 
plate. The micropillar chips were air dried for a minimum of 1 h before dispensing 40 nL
of 0.25% PuraMatrix onto the chips using a S+ microarray spotter (Samsung 
ElectroMechanics, Co. or SEMCO). Samples were dried again for a minimum of 4 h. 
Samples that were not printed with cells within 24 h were stored in the refrigerator for 
future use. Hep3B cells were printed at a concentration of 4 million cells/mL in 0.25% 
PuraMatrix containing 10% (w∕v) sucrose onto the micropillar chips using a 40 
nL/micropillar printing protocol with the S+ microarrayer. Following printing, Hep3B cells
were allowed to sit for 5 min before sandwiching (or “stamping”) with pre-warmed 
microwell chips containing complete RPMI. The sandwiched chips were kept in
humidified chambers at 37oC and 5% CO2 for 30 min before stamping with a fresh, pre- 
warmed microwell chip containing complete RPMI. Hep3B cells in PuraMatrix were then
incubated 48 h in the microwell chips containing complete RPMI before live-dead cell 
staining was performed. Hep3B cells were imaged with a multiband filter using an initial 
gain of 150. Both staining and imaging protocols are detailed near the end of the 
experimental section. In addition to cell viability, the formation of bubbles was 
characterized as a measure of air-liquid interfaces generated by the interaction of the 
polymer with the cell culture media. Spot detachment was also quantified by calculating 
the percentage of micropillars that did not maintain covalent attachment with the hydrogel.
2.2.5. Printing of PuraMatrix gelation agents
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Our optimized surface coating chemistry is provided in Figure 3. Micropillar chips
were coated with 0.01% (w∕v) PMA-OD in ethanol and dried under ambient air for 4 h. To
enhance affinity between PMA-OD coating and cell-PuraMatrix spots, 0.25% PuraMatrix 
in sterile deionized water was printed on the micropillar chips using the S+ microarrayer 
at 60 nL/micropillar and dried under ambient air for 4-24 h. 60 nL/micropillar of gelation
agents were printed onto the micropillar chips and dried under ambient air for 4 h. Potential 
gelation agents tested were sterile deionized water (control), Dulbecco’s phosphate- 
buffered saline (D-PBS), 0.01% alginate, 0.01% PLL, ¼ diluted saline solution (containing 
37.5 mM NaCl and 5 mM CaCl2), and 25 mM BaCl2. Microwell chips were printed with 
950 nL of complete RPMI per microwell using the S+ microarrayer, which were warmed
to 37oC in a 5% CO2 incubator 1 h before stamping with micropillar chips. To reduce the
viscosity of PuraMatrix, 1% (w∕v) stock of PuraMatrix was sonicated for 30-60 min before 
printing. Hep3B cells were trypsinized and centrifuged at 200 g for 4 min using Eppendorf
centrifuge 5702. The supernatant was discarded, the cell pellet was resuspended in RPMI 
1640 containing 10% FBS, and then the cell number was counted with an ORFLO Moxi Z
Mini Automated Cell Counter (MXZ000). Hep3B cell suspension was centrifuged again at 
200 g for 4 min. The supernatant was discarded, and the cell pellet was gently resuspended 
in 7 mL of warmed 10% sucrose. The cells were centrifuged again at 200 g for 5 min. The
supernatant sucrose was discarded, and Hep3B cells were resuspended in 10% sucrose to 
a final concentration of either 8 million or 12 million cells/mL. The resuspended cells were
combined with 20% sucrose and 1% PuraMatrix in a 2:1:1 ratio to create a final cell sample 
containing either 4 million or 6 million cells/mL in 0.25% PuraMatrix containing 10%
sucrose. 60 nL of these cell samples were printed onto each micropillar of the chip.
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Micropillar chips were stamped with microwell chips containing complete RPMI and
incubated at 37oC in a 5% CO2 incubator for 30 min. For the 6 million cells/mL micropillar
chips and some of the 4 million cells/mL micropillar chips, there was a second stamping 
and 30 min incubation with microwell chips containing complete RPMI, as this stamping
process serves to neutralize the highly acidic PuraMatrix. After the fιrst/second rinsing, 
Hep3B cells were stamped again with a microwell chip containing complete RPMI and
incubated at 37oC in a 5% CO2 incubator for 72 h. Micropillar chips were subsequently
stained with a dye solution containing 0.5 μM calcein and 0.5 μM ethidium homodimer in 
D-PBS. Cell images were acquired using a S+ scanner (SEMCO) under 4x magnification, 
multiband filter, and a gain of 150. Cell viability was quantified using the ColorSplit macro 
in ImageJ to quantify the green fluorescence intensity, and spot detachment was counted
Figure 3. Optimized surface chemistry for printing Hep3B cells encapsulated in 
PuraMatrix onto the micropillar chip.
2.2.6. Adenoviral expansion and titering
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Genes for green fluorescent protein (GFP) and red fluorescent protein (RFP) were 
coded into an adenoviral expression system using the protocols from Kwon et. al. to 
generate recombinant adenoviruses carrying genes for GFP (Ad-GFP) and RFP (Ad-RFP) 
[136]. HEK293 cells were used to expand the adenoviruses. T75 flasks were seeded at 50- 
70% confluency and grown for twenty-four hours in EMEM containing 10% FBS before
exposure to the viruses. Cells were incubated with the viruses and serum-free EMEM using 
a multiplicity of infection (MOI) of fifty for 24 h. The growth medium was removed and 
replaced with serum-free EMEM. When significant cytopathic effect (CPE) was observed 
(usually 2-4 days after the viral particles were removed), the infected HEK293 cells and 
media were removed from the flask. To lyse the cells and release the viral particles into the
media, cells underwent three rapid freeze-thaw cycles where cells were frozen at -80°C for
30 min, followed by thawing at 37oC for 10 min. The cells were centrifuged at 1500 g for
5 min at 4oC to remove the debris. The supernatant was placed in a centrifugal filter unit
with a molecular weight cut-off (MWCO) of 100,000 kDa and centrifuged at 4,000 g at
4oC for 45 min. Viral particles were washed twice with 10 mL bronchial epithelial cell
growth medium (BEGM) without additives using the centrifugal filter unit before being 
resuspended in 1 mL serum-free BEGM. To determine adenoviral titer, an end-point 
dilution assay was used, utilizing HEK293 cells to determine CPE [147]. Final Ad-GFP 
and Ad-RFP stock concentrations ranged between 108 and 10l0 PFU∕mL.
2.2.7. Adenoviral transduction in PuraMatrix
Hep3B cells were printed using the optimized gelation agent (water) as described 
earlier in the materials and methods section, using two media washes and a seeding density
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of 6 million cells/mL. After 24 h of incubation in complete RPMI, 950 nL of the
adenoviruses in complete RPMI were printed into microwell chips, and Hep3B cells were 
exposed to various MOI of the adenoviruses for 24 h. Following adenoviral exposure, the 
microwell chip was discarded and replaced with a microwell chip containing fresh 
complete RPMI. The micropillar chips were incubated for additional 48 h before being 
dried under ambient air in a dark environment for another 24 h. Fluorescent cell images 
were obtained with the S+ scanner using a multiband filter, and individual green and orange 
filters at 4x magnification. A gain of 100 was used to examine fluorescence.
2.2.8. Drug toxicity assessment
Hep3B cells were printed at the optimum condition described in the adenoviral 
transduction procedure. After 24 h of incubation, six model compounds were printed into 
microwell chips at six dosages per compound. Tested compounds include acetaminophen 
(2.10 - 2125 μM), lovastatin (0.03 - 29.5 μM), rotenone (0.03 - 29.5 μM), tamoxifen (0.03 
- 29.5 μM), menadione (0.04 - 44.3 μM), and sodium citrate (1.38 - 1417 μM). Compounds
were four-fold serially diluted in complete RPMI starting with the highest concentration of 
a tested compound to develop dose-response curves. Following 48 h of Hep3B cell 
exposure to the compounds, the cells were stained and imaged for viability as described in
Section 2.9.
2.2.9. Live-dead ceil staining and image acquisition
Micropillar chips were rinsed via submersion in 5.5 mL of D-PBS in a deep-well
staining plate for 5 min twice. Any excess D-PBS solution from the chip was drained by 
tilting the chip at an angle of 45° and removing the remaining solution from the side of the
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chip with a paper towel. A dye solution containing 0.5 μM calcein and 0.5 μM ethidium 
homodimer in D-PBS was used for live-dead cell staining. Hep3B cells were stained in a 
shallow-well staining plate in the dark using 2 mF of the dye solution per well for 1 h. The 
cells were then rinsed with 5.5 mL of D-PBS in the deep-well staining plate for 15 min
twice. Following the last wash, the excess water was drained from the chip and the cells 
were left to dιy overnight in the dark before imaging with the S+ scanner. Cell images were 
acquired using the S+ scanner under 4x magnification, multiband filter, and a gain of 150.
2.2.10. Analysis of cell images
All images were separated for analysis based on color using the ImageJ plugin in 
“ColorSplit”, which splits the colors of individual images into distinct red, green, and blue 
emission spectra. Each image underwent a basic background subtraction, followed by 
thresholding using the moments method [148]. Finally, the total fluorescence in the image 
was quantified using an integrated density function.
2.2.11. Statistical analysis
Fluorescence intensities obtained from Hep3B cells exposed to media alone 
(control) and compounds were plotted as a function of dosages using S+ chip analysis 
software to generate dose response curves and calculate IC50 values [141]. In addition, 
average, standard deviation (SD), and standard error mean (SEM) of sample fluorescence 
were calculated for analysis of variance (ANOVA) using GraphPad Prism 4. Samples 
exposed to various compounds underwent dose-response curve plotting using the S+ chip 
analysis software.
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2.3. Results
2.3.1. Optimization of polymer coating on the micropillar chip for PuraMatrix attachment
The amphiphilic polymers chosen for surface coating of the micropillar chip
include maleic anhydride analogs. The carboxylic groups from hydrolyzed maleic 
anhydride may have ionic interactions with the positively charged arginine residues on 
PuraMatrix, while the main alkyl and ethylene/propylene oxide chains may have 
hydrophobic interactions with the micropillar chip made of polystyrene (Figure 2). This 
results in a situation where these polymers can anchor PuraMatrix onto the surface of the 
micropillar chip. Additionally, while PuraMatrix contains amine functional groups, these
polymers can conjugate to any hydrogel containing amine functional groups, or cross- 
linking molecules containing amine functional groups such as poly-L-lysine.
The results of the polymer coating experiment on micropillar chips are summarized 
in Table 2. It was found that six out of the seven tested polymers were soluble in ethanol. 
The one that was insoluble in ethanol, AKM1510, was also insoluble in water; this polymer 
was subsequently excluded for further surface coating experiments. Of the six remaining 
polymers, three dissolved in water (ADM1510, AEM1510, and AKM0530), while three 
formed colloidal suspensions (ACM1510, PMA-OD, and PMA-TD) at a 0.1 % (weight per
volume, or w/v) concentration. The initial polymer coating condition at 0.1% (w/v) proved 
to be too toxic to Hep3B cells presumably due to polymer leaching so that the concentration 
was diluted to 0.01% (w∕v) to minimize basal toxicity.
Table 2. Polymers used for coating the micropillar chip made of polystyrene.
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Polymers 
used for 
coating
Length 
of chains
a
EO/AO
b (%)
Solubility 
in ethanol
Solubility 
in water
Bubble
formation
Spot
detachment
(%)
ACM1510 m = 26 k= 10 20
+ c - ++ 1 ±0.5d
ADM1510 m = 27 k= 10 30
+ + + 13 ±5
AEM1510 m = 28 k= 10 40
+ + + 19 ± 12
AKM0530 m= 10 k = 30 100
+ + - 12± 15
AKM1510 m = 33 k= 10 100 - - N/A N/A
PMA-OD n = 16 N/A + — — 0
PMA-TD n= 12 N/A + — + 0
No coating N/A N/A N/A N/A - 25 ± 16
a Chains refer to the number of repeating units in the structures described in Fig 2.
b Ethylene oxide (EO), alkylene oxide (AO), propylene oxide (PO). AO = EO + PO. For 
where these oxides are in the polymer, see Fig 2.
c “++” denotes the aspect was greatly observed above the normal, “+” denotes the aspect 
was somewhat observed, and denotes that the aspect was not observed. 
d “±” denotes standard deviation (SD)
For cell-based assays on the micropillar chip, bubble formation and spot 
detachment were tested. Air bubbles entrapped between the hydrogel spot on the 
micropillar chip and the growth media in the microwell chip imply that the surface of
polymer coating may not be uniform, or a polymer may be unsuitable for coating. With 
excess air bubbles, cells encapsulated in hydrogels may experience nutrient deficiency and 
could potentially dry out. In addition, robust spot attachment on the micropillar chip is 
critical for 3D cell culture and imaging. Uniform surface coating of a polymer and the 
affinity of a bottom layer between the PuraMatrix spot and the polymer-coated surface of 
the micropillar chip play a significant role.
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When examining the chips, bubble formation was only absent in the cases of 
AKM0530 and PMA-OD, while excess bubbles were observed with ACM1510 coating.
This result indicates that there is no correlation between bubble formation and the
hydrophobicity of the coating polymers or their alkyl/alkylene oxide chain lengths. We 
suspect bubble formation occurs due to the presence of dissolved O2 in the media that could 
collect at the surface of the micropillar chips though we could not tie this to a particular 
property associated with any of the dissolved polymers.
When spot detachment was calculated, it was found that PuraMatrix detached more 
readily with hydrophilic polymer coating over hydrophobic polymer coating. We 
hypothesize that this detachment was due to relatively high solubility of the hydrophilic 
polymers in growth media, leading to weak interactions between PuraMatrix and the 
surface of the micropillar chip. In contrast with the hydrophilic polymers, the hydrophobic 
polymers will be remained intact on the surface of the micropillar chip for interactions with 
PuraMatrix. In the case of the no-surface treatment control, we found that spot attachment 
was reduced although bubble formation was not an issue. Overall, PMA-OD found to be 
the best coating with PuraMatrix due to robust spot attachment and no bubble formation. 
Therefore, all subsequent experiments were conducted on the micropillar chip coated with 
0.01% (w∕v) PMA-OD (Figure 3).
2.3.2. Salts and ionic polymers for gelation of PuraMatrix and enhanced spot attachment
Tests were performed to determine if there are additional salts or ionic polymers 
necessary to ensure robust spot attachment immediately after cell printing in PuraMatrix. 
The results of using the various salts and ionic polymers as gelation mechanisms are
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summarized in Figure 4. In general, salts in growth media are used as a gelation agent for 
PuraMatrix as they facilitate the self-assembly of the hydrogel, resulting in a β-sheet type 
structure [149,150]. The bonds that hold the hydrogel together include ionic interactions 
between the aspartic acid and arginine residues, hydrophobic interactions between the 
alanine residues, and hydrogen bonding associated with the β-sheet type structure [151— 
154]. Significant spot detachment was only observed when D-PBS without Ca2+ and Mg2+ 
was printed on 0.01% (w∕v) PMA-OD coating to assist PuraMatrix gelation (Figure 4B). It 
is hard to deduce why D-PBS was so unfavorable for PuraMatrix spot attachment given 
that the diluted saline and BaCl2 solutions showed high spot attachment levels. Perhaps, 
excess salt crystals formed on the surface of the micropillar chip due to high concentration 
of NaCl (137 mM) in D-PBS prohibit robust attachment of PuraMatrix droplets on the 
surface. Interestingly, PuraMatrix droplets were robustly attached on the surface of the 
micropillar chip without any salts and ionic polymers added, which indicate that salts in 
growth media are sufficient to form PuraMatrix gelation, and PuraMatrix spots printed are 
adherent to PMA-OD coating.
Day 0 Day 1 Day 2 Day 3
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Figure 4. (A) Bright-field microscopic images of Hep3B cells in PuraMatrix printed on 
the micropillar chip and cultured over time in combination with the microwell chip. The 
scale bar is 200 μm. (B) Detachment of PuraMatrix droplets containing Hep3B cells (60 
nL/spot at 6 million cells/mL) as a function of salts and ionic polymers used for PuraMatrix 
gelation after two media washes. (C) Hep3B cell viability as a function of salts and ionic 
polymers used at different cell seeding and wash conditions. Error bars represent SEMs, n 
= 72.
Hep3B cell viability was measured on the salt and ionic polymer layer at different 
cell seeding density and media wash conditions (Figure 4C). Overall, Hep3B cells were 
viable within PuraMatrix, and cell viability was somewhat reduced in the presence of 25 
mM BaCl2 and 0.01% (w∕v) PLL, but not significantly in either. As PuraMatrix is acidic, 
we decided to test the effects of additional growth media rinsing in the microwell chip and 
high cell seeding density. Briefly, the mixture of PuraMatrix and Hep3B cells was
prepared by rinsing the Hep3B cell pellet with sucrose, centrifuging the cell-sucrose 
mixture, and then resuspending the cell pellet in the mixture of PuraMatrix-sucrose at a 
seeding density of 4 or 6 million cells/mL. To further neutralize acids in PuraMatrix, 
freshly printed Hep3B cells on the micropillar chip were rinsed with an additional 
microwell chip containing fresh growth media 30 min after cell printing. Overall,
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increasing from one to two media washes increased Hep3B cell viability as described in 
manufacturer’s instruction for 96-well plate cultures. In addition, we noticed that additional 
sucrose rinsing to remove salts in growth media can disturb cell membrane integrity, 
leading to low cell viability. Therefore, sucrose rinsing was performed once very gently 
without vigorous pipetting. Finally, cell seeding density greatly affected the viability of 
Hep3B cells in PuraMatrix on the chip. Increasing cell seeding density from 4 to 6 million
cells/mL resulted in higher cell viability and increased reproducibility. The biggest 
contributors towards improving cell viability involved increasing the number of media 
washes and the cell seeding density.
Since additional salts and ionic polymers did not significantly enhance spot 
attachment and cell viability, we decided to eliminate this step. Therefore, all subsequent 
experiments were conducted on the 0.01% (w∕v) PMA-OD-coated micropillar chip with 
60 nL of 6 million Hep3B cells/mL (360 cells seeded per micropillar) after two media
washes. Hep3B cells in PuraMatrix formed 3D spheroid structure over time in this 
condition (Figure 4A).
2.3.3. Adenoviral transductions
With the optimized Hep3B cell culture condition in PuraMatrix on the chip,
adenoviral transduction was performed in the presence of recombinant adenoviruses 
carrying genes for green fluorescent protein (Ad-GFP) and red fluorescent protein (Ad- 
RFP), and the results are shown in Figure 5. Adenoviral transduction is important as a 
method to efficiently deliver genes such as metabolizing enzyme genes and control protein 
expression in vitro, as to develop predictive cell models for testing the toxicity of
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compounds [136]. However, adenoviral gene delivery is often difficult in 3D systems due 
to strong interactions of virus particles with a hydrogel matrix and diffusion issues into 3D 
constructs. Unlike alginate, PuraMatrix successfully facilitated adenoviral gene 
transduction on 3D-cultured Hep3B cells as demonstrated with individual Ad-GFP and Ad- 
RFP (Figure 5). Hep3B cells transduced with both Ad-GFP and Ad-RFP exhibited a 
yellow-orange color, indicating that both green and red fluorescent proteins were 
simultaneously expressed and detected by a multiband filter. Analysis of fluorescence 
intensity at different MOI showed that both GFP and RFP exhibited dose-dependent 
fluorescence intensity changes, with the exception that the 10 MOI Ad-RFP showed 
slightly reduced fluorescence compared to the 5 MOI Ad-RFP alone. This may be caused 
by red fluorescence generally being weaker than green fluorescence, particularly when 
cells have been infected with both viruses and are exhibiting yellow fluorescence.
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Figure 5. Adenoviruses transduced into Hep3B cells encapsulated in PuraMatrix on the 
micropillar chip. A) From left to right, images showing transduction in the presence of no 
virus, 5 MOI Ad-GFP, 20 MOI Ad-GFP, 10 MOI Ad-GFP + 10 MOI Ad-RFP, 5 MOI Ad- 
RFP, and 20 MOI Ad-RFP. B) Corresponding fluorescence intensity measurements 
observed on the micropillar chip. Error bars represent SEMs, n = 72.
2.3.4. Drug toxicity assays
Six model compounds were tested on 3D-cultured Hep3B cells in PuraMatrix to 
demonstrate the capability of the chip platform for rapid toxicity assessment (Figure 6). 
The IC50 data from 3D-cultured Hep3B cells on the chip were compared with the in vitro 
IC50 data from HepG2 cell monolayers in 2D, IC50 values from human hepatocytes, in vivo 
human Cmax values, and iu vivo LD50 data from mice exposed orally to these compounds 
(Table 3). The iu vivo data were sourced from Sigma for acetaminophen, lovastatin, 
Cayman Chemicals for rotenone and tamoxifen, Applichem for menadione, and Sagent 
Pharmaceuticals for sodium citrate. Acetaminophen and sodium citrate were found to be
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non-toxic for the range of compound concentrations tested, which is consistent with 
previous experiments in 2D using the micropillar chips [136], and with other previously
cited literature values from 2D experiments [152-155]. All drug concentrations tested had 
IC50 values within one order of magnitude of in vitro toxicity data, with Hep3B cells 
encapsulated in PuraMatrix exhibiting normal dose-response type behavior, with increased 
concentrations of compounds reducing cell viability and the middle range of concentrations 
producing a more dramatic shift in cell viability. These results point towards the ability of 
Hep3B cells encapsulated in PuraMatrix to be used to assess potential drug toxicity in the
liver.
Table 3. Comparison of IC50 and LD50 values of the model compounds.
Compound
3D Hep3B
IC from
50
the chip 
(μM)
2D HepG2 IC 
r 50
from literature 
(μM)
Human
Hepatocyte IC50 
from literature 
(μM)
Cmax from 
literature 
(μM)
Mouse oral
LD from
50
MSDS
(mg∕kg)
Acetaminophen >2100 630 (Neutral red assay) [154]
28200 (MTT) 
[156] 130 [157,158] 338
Lovastatin 23 20 ±3.7 (MTT) [159]
96 (CYP3A4 
activity) [160]
0.01
[157,158] >1000
Rotenone 2.4 0.5 ± 0.1 (Fluo-4 AM) [155]
1.0 (CellTiterGlo) 
[161]
50
[155,157,158] 2.8
Tamoxifen 4.3 60 ± 5.9 (Fluo-4 AM) [155]
21.5-98.4
(CellTiterGlo)
[162]
0.4
[155,157,158] 2200
Menadione 1.2 13 (Luc-CEE) [163]
4.2 (TMRM) 
[164]
5
[157,158,165] 500
Sodium Citrate >1400 >1000 (Fluo-4 AM) [155]
>1000 (Hoechst) 
[166]
N/A
[155,157] 5000
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B
Figure 6. (A) Representative image of Hep3B cells encapsulated in PuraMatrix treated 
with menadione (low dosage: 43 nM, high dosage: 44.3 μM). (B) Dose response curves of 
Hep3B cells exposed to the model compounds while encapsulated in PuraMatrix on the 
micropillar chip, n = 12.
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2.4. Discussion
The goal of this research was to design a chip platform containing hepatic cells in 
a 3D biomimetic microenvironment that can be suited for rapid assessment of potential 
drug candidates and controlled expression of genes via viral transduction. PuraMatrix was 
selected as an analog for cellular ECMs as the peptide structure is used for anchoring sites 
of the cellular integrins to attach [111,144]. Generally, PuraMatrix has been used for 
applications in neural tissue engineering, as the hydrogel has mechanical properties similar 
to that of other hydrogels used for neural ECM substitutes [111]. PuraMatrix also forms
fibrous strands similar to that of the tracks found in the white matter of the brain [111].
While the liver does not necessarily contain the exact architecture of these tracks, integrins 
are important for cells to adhere to the ECM in any tissue or organ.
Initially, surface chemistry needed to be optimized for PuraMatrix attachment onto 
the micropillar chip. This part was of particular importance as a good attachment serves to 
provide numerous replicates for experiments, making the micropillar chip a suitable 
platform for cell culture and imaging. Additionally, surface chemistry developed may be 
applied towards hydrogels other than PuraMatrix. In particular, coating the surface of the 
micropillar chip with 0.01% (w∕v) PMA-OD in ethanol creates a favorable interaction 
between the micropillars and the amine-reactive polymers and hydrogels as now the 
micropillar chip has been functionalized with amine-reactive maleic anhydride groups, 
while there is an anchor formed via the hydrophobic interactions between the micropillar 
chip made of polystyrene and the alkyl side chains from PMA-OD. Since spot detachment 
was positively correlated with hydrophobicity, this makes PMA-OD a good choice for 
ensuring the robustness of the surface chemistry. Ultimately, PMA-OD was a better choice
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than ACM 1510 or PMA-TD because of the lack of bubbles formed when using PMA-OD, 
which means that PMA-OD also does not impede the ability of cells in hydrogels to come 
into contact with media, creating an environment ideal for microscale 3D cell culture.
As another part of this study, it was necessary to observe if printing salts and ionic 
polymers on the surface of the micropillars will result in improved attachment of 
PuraMatrix. PuraMatrix forms a gel in the presence of salts, which promotes ionic 
interactions between arginine and aspartic acid; thus, Hep3B cells suspended in PuraMatrix 
must be pretreated with 10% (w∕v) sucrose which is both isotonic and non-ionic. It was 
initially hypothesized that printing salts would hasten the gelation process once Hep3B 
cells in PuraMatrix were printed on the micropillar chip. In addition, a pre-printing step of
diluted PuraMatrix was used to provide high affinity to the PMA-OD-coated micropillars 
for which the cell-laden PuraMatrix may attach. The results showed that printing of the 
salts and ionic polymers seems to be unnecessary as a method for improving surface 
attachment. In the case of D-PBS, the printing of high concentrations of salts significantly 
increased the detachment of PuraMatrix spots, and thus decreased the number of spots that 
could be analyzed. The results indicate that salts in growth media are sufficient for gelation, 
and PuraMatrix gelation prior to immersion in growth media is unnecessary presumably 
due to high affinity of the PuraMatrix bottom layer.
More importantly, PuraMatrix exists at an acidic pH of 2-3, which is toxic to Hep3B 
cells and needs to be neutralized for 3D cell culture. This is supported by two results: 1) 
neutralizing PuraMatrix with two media washes provided more consistent, highly viable 
cells and 2) increasing the cell density from 4 million cells/mL to 6 million cells/mL
effectively increased the exhibited green fluorescence intensity (and thus, the amount of
50
live cells) and decreased in spot-to-spot variation. Both results were independent of the 
salts and ionic polymers used to initiate gelation. While the 3D cell culture on the 
micropillar chip focused on optimization of gelation conditions for PuraMatrix, previous 
experimental protocols utilized PBS [103,149] or culture media [111,149] to initiate
gelation. The results of the experiments performed on the micropillar chip indicate that D- 
PBS is not a suitable gelation agent for PuraMatrix for this scaffold, indicating the 
importance of using divalent cations as supposed to monovalent cations for improved 
surface attachment and gelation of PuraMatrix.
The major drawback of using PuraMatrix is that the preparation for cell printing 
relies on several steps that could be toxic and time-sensitive. This may make PuraMatrix 
unsuitable to be used for cell types that may be averse to these harsh conditions. It because 
of the low pH of PuraMatrix that it was necessary to subsequently increase cell seeding 
density in the spots and wash each chip twice with excess growth media to neutralize the 
pH of PuraMatrix. While these steps did make results for subsequent experiments more 
consistent, and improve general culture conditions, Hep3B cell growth seems to be 
generally less than that experienced in other hydrogel cultures [143]. This is particularly 
apparent with less spheroid formation, a general indicator that Hep3B cells are thriving in
3D.
The major advantage towards using PuraMatrix is the fact that it can be used to 
encapsulate cells while having minimal interactions with viral capsids, allowing for 
controlling the expression levels of key enzymes [136,167] Adenoviruses were designed 
for expansion in HEK293 cells as an expression vector due to their relatively low 
pathogenicity and their expression is transient in nature [136,143]. The results conclusively
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show the ability for Hep3B cells to be infected with adenoviruses while encapsulated in 
PuraMatrix. Additionally, the S+ scanner imaging system can distinguish Hep3B cells 
expressing GFP and RFP, while the cells exhibited MOI-dependent infection capability. 
Although Hep3B cells in PuraMatrix on the chip were used for infection with adenoviruses 
carrying genes for GFP and RFP, our approach could be further expanded to include 
various other viruses, allowing for control of genetic expression of enzymes and proteins 
important in drug discovery.
After successful adenoviral transduction, adverse drug responses were monitored 
via Hep3B cell exposure to six model compounds at different concentrations and measured
their relative toxicities. Results showed that the IC50 values obtained from 3D-cultured
Hep3B cells in PuraMatrix were similar to those obtained from HepG2 cells in 2D for four
out of six compounds yet not quite perfectly aligned with the toxicity values observed from 
in vivo animal data obtained from the chemical manufacturers [156,159,163]. Additionally,
there are differences between Cmax literature values and the calculated IC50 values for
Hep3B in PuraMatrix [ 155,157,158]. These variations can be attributed to the nature of 
metabolism and clearance being heavily dependent on the genetic makeup of drug 
metabolizing enzymes (DMEs) and drug transporters. Therefore, in vivo toxicity data from 
animals and humans can be completely different. Among hepatic cell lines, in vitro toxicity
data can be also varied depending on the levels of DME expression. For example, 
acetaminophen is a well-known metabolism-sensitive compound, which is activated in the 
presence of DMEs such as cytochrome P450 (CYP450) isoforms. Unlike primary
hepatocytes, Hep3B cells don’t express high levels of DMEs [168], leading to no activation 
of acetaminophen on the chip platform. In addition, tamoxifen is metabolized by a variety
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of CYP450 isoforms, a key family of enzymes expressed within the liver [169]. In the cases
of Hep3B and HepG2, both cell lines experience significant decreases in the expression of
CYP450 2D6 (CYP2D6), the isoform most associated with tamoxifen metabolism
[168,169]. Likewise, menadione metabolism is heavily dependent on CYP450s for
adequate clearance [170]. In the case of other compounds, significant differences can exist 
between in vivo and in vitro data because the in vitro experiments cannot account for all 
drug metabolism. For lovastatin, metabolism occurs both in the liver and the intestine [160] 
The ultimate effect of this are multiple cell types that can metabolize a potentially harmful 
drug, which reduces the toxicity observed in vivo compared to in vitro. In the case of other 
compounds, the results were consistent with both in vivo and in vitro results. This is true 
for sodium citrate, a generally nontoxic salt, and rotenone, whose mechanism of action 
affects mitochondria, which is present in many cell types, though in very high levels in 
hepatocytes [161]. In the case of acetaminophen, the general mechanism of toxicity is also 
associated with impaired mitochondrial function [171,172]. This is particularly apparent 
when comparing rat and mouse in vivo results, where rats are less susceptible to oxidative 
stress from acetaminophen because of their elevated levels of mitochondria per hepatocyte 
as compared to mice [172]. Overall, the IC50 values of tamoxifen and menadione were 
reduced in the presence of PuraMatrix on the chip as compared to other in vitro data. This 
could be potentially due to the additive effects of toxicity from the test compounds and 
PuraMatrix. Since it was necessary to increase cell seeding density to improve Hep3B cell 
viability on the micropillar chip, it is also possible that cells exhibited a decreased tolerance 
towards these compounds due to the added stresses. Additionally, these reductions may 
also be due to the effect of culturing cells in 3D instead of 2D, as cells cultured in 3D
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experience cues from more cells than cells grown in 2D, including potential triggers for 
cell death. Regardless, discrepancies between PuraMatrix, in vivo, and other in vitro results 
can be attributed to the varying nature of metabolism presented in these experiments and 
any stresses associated with using PuraMatrix as a scaffold for Hep3B cell growth.
The developed platform can replicate toxic reactions, but there are some drawbacks 
to this system. The use of PuraMatrix is tricky as its pH requires several neutralization 
steps after printing and makes it tricky for use larger scale 3D cultures. Additionally, 
because it gels in the presence of salts, it necessitates cells to be resuspended in an isotonic, 
10 % sucrose solution. This resuspension causes cells to clump and can also be toxic if 
cells are kept in suspension for long periods of time.
Another drawback is the scale of the platform. The size of the microwell chip and 
the micropillar chip means total droplet size cannot be greater than 60 nL per spot, or the 
hydrogel could hit the bottom surface of the microwell chip. Because the droplet is so small 
in size, the depth in which cells form 3D structures is equal to only two cell diameters. 
Thus, while there is some 3D organization, the thickness means that drugs can easily 
diffuse through all cell layers, which is not necessarily the case for larger scale 3D or in
vivo cell cultures.
2.5. Conclusions
Here, it has been demonstrated that PMA-OD can improve PuraMatrix attachment 
on the surface of the hydrophobic micropillar chip made of polystyrene. A procedure was 
optimized by which Hep3B cells encapsulated in PuraMatrix can be cultured on the chip
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for low-volume, high-throughput applications. In addition, genetic expression was 
successfully modified via adenoviral transduction of Hep3B cells encapsulated in 
PuraMatrix on the micropillar chip, which can be potentially extended to gain- and loss- 
of-function studies such as metabolism-induced toxicity of compounds by over-expressed 
DMEs or lack of specific DMEs. While toxicity did not perfectly correlate with in vivo
data, much of this can be attributed to differences between in vivo and in vitro metabolism
and its contribution to toxicity. Potential variations between in vitro data can be associated 
with stresses put on cells encapsulated in PuraMatrix, or differences between cell types and 
the comparison of cells in 2D vs. cells in 3D.
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CHAPTER III
OPTIMIZATION OF OXYMETHACRYLATED ALGINATE (OMA) FOR USE
IN MINIATURIZED 3D HEPATIC CELL CULTURES
3.1. Introduction
The majority of in vitro 3D cell culture relies on the use of hydrogels as 
extracellular matrix (ECM) mimics to promote the appropriate interactions between cells 
and their surrounding environment [87,90,102]. While the standard 2D system offers ease 
of set-up, hydrogels provide several distinct advantages over 2D and other 3D systems. 
Namely, hydrogels have flexible chemical and physical properties that allow for cell 
adhesion and growth, providing a stable structure for cells to mature in 
[78,117,118,120,173]. It is the goal of researchers to develop biomimetic, tunable 
hydrogels that can provide the necessary structural and chemical stability to promote cell 
growth and maturation in 3D.
Hydrogels have great diversity in structure and mechanisms for polymerization. 
Common hydrogels include those with polysaccharide structures (alginate [91,142], 
chitosan [137,138], hyaluronic acid [100,174]) and peptide/protein-based structures
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(Matrigel [175,176], fibrin [96,103], collagen [94,96]), and both generalized structures 
may be biologically derived [93,177] or synthesized artificially [88,89,106,111]. Gelation
mechanisms for hydrogels include changes in temperature [95], introducing certain ions 
into the polymer [178], UV-light based polymerization [179], enzyme-catalyzed 
polymerization [127], and changes to pH [180]. With the hundreds of methods and 
compositions used to form hydrogels, it is important to choose an optimum mimic for in
vivo 3D-architectures.
As discussed in the previous chapter, PuraMatrix was not a suitable hydrogel for 
larger scale 3D cultures because the mechanisms for polymerization and its natural pH 
created some toxicity from the cells. Thus, we chose to explore photopolymerizable 
hydrogels. Photopolymerizable hydrogels have durability in their physical properties and 
are more structurally stable than hydrogels that rely on ionic mechanisms of polymerization 
[ 179,181—184]. Photopolymerization relies on the use of a photoinitiator (PI) to generate 
radicals, which can serve as a crosslinker or use radical-based polymerization in the 
presence of hydrogels [183,185,186] Because of the covalent bonds formed during the 
polymerization process, photopolymerized hydrogels are more resistant to degradation 
than hydrogels that rely on ionic coordination or temperature activation for polymerization 
[179,182,186]. However, because of the presence of radicals in solution, there is inherent 
toxicity to the cell due to generation of reactive oxygen species (ROS), which can have a 
variety of effects from DNA damage and loss of protein function to peroxidation of the 
lipid membrane [187,188].
Oxy-methacrylated alginates (OMAs) provides many distinct advantages over 
native alginate. While alginate utilizes divalent cations to initiate ionic crosslinking with
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carboxylic acids, OMA relies on the use of a PI with near-UV light to create covalent 
polymerization. This crosslinking has been demonstrated to be markedly more robust than 
alginate, both mechanically and its resistance to degradation [189]. While OMA has been 
used for a variety of studies, including in vivo implants and drug delivery, the use of OMA 
for microscale tissue culture and as a 3D scaffold on high-throughput platforms is lacking. 
While large scale cultures can potentially mimic more features of the various organs but 
suffer from inefficient nutrient transport and cost associated with the scale [190—193]. 
Miniaturizing these tissue cultures can improve some of these hurdles, yet further 
optimization of crosslinking is necessary, as the consumption of a PI and the penetration 
of light may be different at smaller scales [194,195]. Subsequently, there is a need to better 
understand what happens to cells and hydrogels in miniaturized 3D cell culture.
In this study, we attempted to optimize the parameters for polymerizing OMA 
within a microwell chip with a goal of finding a set of conditions yields stable and viable 
cells in 3D. The microwell chip contains 532 wells capable of holding ~ 1 μL spot volume, 
ideally designed for miniaturized 3D culture (Figure 7). While we have previously utilized 
the microwell chip as a vessel for containing media to be paired with the micropillar chip 
containing cells, we wanted to work with a platform that is more conducive to multi-layered 
3D culture as spot volumes on the micropillar chip are quite small, and only allow for a 
thickness of two cells for 3D structures. We examined a variety of factors affecting 
polymerization, including surface background color, OMA concentration, intensity of light, 
duration of light exposure, and PI concentration. Additionally, we compared results 
between synthesized OMA samples that have different concentrations of methacrylate 
functional groups. We compared viability results and the formation of gels amongst all
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conditions at various heights within the microwell, which ultimately allowed us to assess 
the efficiency of polymerization of OMA in small volumes.
Microwell Chip Hep3B cells in 
(640 nL)
Complete 
RPMI (15 mL) 
in petri plate
Microwell Chip with 
printed cells
A B
C
Figure 7. Schematic representation of (A) a microwell chip with printed Hep3B cells in a 
OMA matrix and (B) that same chip submerged in media in a petri plate. (C) Picture of a 
microwell chip against a microscope glass slide.
3.2. Materials and Methods
3.2.1. Materials
Hep3B human hepatoma cell line (catalog no. HB-8064) and all cell culture 
ingredients, including RPMI, fetal bovine serum (FBS), penicillin-streptomycin (PS), and
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gentamicin were provided from ATCC. The microwell chips were manufactured by MBD 
Korea (Suwon, South Korea). Staining solutions, including calcein AM and ethidium 
homodimer-1 were purchased from ThermoFisher. 2-Hydroxy-4'-(2-hydroxyethoxy)-2- 
methylpropiophenone (trade name, Irgacure2959, catalog no. 410896) for
photopolymerization was obtained from Sigma Aldrich.
3.2.2. OMA Synthesis
OMA-15 and OMA-45 were prepared by the previously reported method with 
modification by Dr. Oju Jeon and Dr. Eben Alsberg from Case Western Reserve University 
[181,189]. Briefly, sodium alginate (10 g, Protanal LF 20/40, FMC Biopolymer) was
dissolved in ultrapure deionized water (diH2O, 900 ml) overnight. Sodium periodate (1 and 
1.75 g, Sigma) was dissolved in 100 ml diH2O, added into separate alginate solutions under 
stirring to achieve 10 and 17.5 % theoretical alginate oxidation, and allowed to react in the 
dark at room temperature for 24 hrs. The oxidized, methacrylated alginate (OMA) 
macromers were prepared by reacting OA with 2-aminoethyl methacrylate (AEMA). To 
synthesize OMA, 2-morpholinoethanesulfonic acid (MES, 9.76 g, Sigma) and NaCl (8.765
g) were directly added to an OA solution (500 L) and the pH was adjusted to 6.5. N- 
hydroxysuccinimide (NHS,0.44 and 1.325 g, Sigma) and l-ethyl-3-(3- 
dimethylaminopropyl)-carbodiimide hydrochloride (EDC, 1.46 sand 4.375 g, Sigma) were
added to the mixture under Stirling to activate 15 and 45 % of the carboxylic acid groups 
of the alginate, respectively. After 5 min, AEMA (0.635 and 1.9 g, Polysciences) (molar
ratio of NHS:EDC:AEMA = 1:2:1) was added to the solution, and the reaction was
maintained in the dark at RT for 24 hrs. The reaction mixture was precipitated into excess 
of acetone, dried in a fume hood, and rehydrated to a 1 % w/v solution in diH2O for further
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purification. The OMA was purified by dialysis against diH2O using a dialysis membrane 
(MWCO 3500, Spectrum Laboratories Inc.) for 3 days, treated with activated charcoal (5 
g/L, 50-200 mesh, Fisher) for 30 min, filtered (0.22 μm filter) and lyophilized.
3.2.3. Plasma Treatment of Microwell Chips
Polystyrene microwell chips were exposed to plasma using a PDC-001-HP high 
power expanded plasma cleaner from Harrick Plasma. Up to ten microwell chips were laid 
out on the pyrex loading plate and placed inside the chamber. Initially, the chamber, 3-way 
valve, and metering valve were closed before the machine and vacuum were turned on for 
five minutes, lowering the chamber pressure to 100-200 mTorr. The three-way valve was 
opened to the processing position, and air was bled in at 250-350 mTorr for one minute. 
Following initial air processing, the plasma RF power was turned onto “medium” or “high” 
for one minute. Finally, RF power was maintained, and the metering valve was adjusted 
for air processing at 800-1000 mTorr for 5, 10, 15 and 20 minutes. After the final
processing, samples were tested for successful treatment by immersing chips in 15 mL 
complete media in a petri plate following treatment. The microwells containing bubbles 
were evaluated as a function of the percentage of total microwells. We subsequently used 
the protocol that gave us the fewest average amount of bubbles. From this point forward, 
all samples were stored at room temperature for up to three days before cell printing
occurred.
3.2.4. Preparation of OMA and PI
To create a 12 w/v % OMA solution, 120 mg of OMA-15 with 5% oxidation and 
OMA-45 with 17.5 % oxidation were separately dissolved in 1 mL complete RPMI
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containing 10 v/v % fetal bovine serum (FBS), 1 v/v % penicillin and streptomycin (PS), 
and 0.1 v/v % gentamicin. Dissolving OMA consisted of vigorous manual mixing using a 
sterile spatula followed by vortexing and then centrifuging at 500 g for 5 minutes. This 
process was repeated up to twice until completely dissolved. If OMA was not adequately 
dissolved after three cycles of manual mixing, vortexing, and centrifugation, the sample 
was discarded, and dissolving started with a fresh sample. OMA is printed and polymerized 
one day after being dissolved in complete RPMI and is stored room temperature if printing 
occurs within one hour of dissolution, or at 4oC should it occur later. For polymerization 
and ease of mixing, 100 mg of Irgacure-2959 was dissolved in 1 mL of 70 v/v % ethanol
via vortexing to a final concentration of 10 v/v %. Dissolved PI was stored at 4oC for up to 
a week before printing.
3.2.5. Printing Hep3B Cells in Microwell Chips
Hep3B cells (P15-P50) were cultured in RPMI + 10 % FBS + 1 % PS in T-75 flasks
and grown to 90% confluence before passaging. Before printing, cells were resuspended 
to concentrations of 8 or 12 x 106 cells/mL in complete media. Cells, OMA, Irgacure2959, 
and complete media were mixed for the final printed solution, with concentrated cells 
representing half of the volume of the printed sample. The final concentrations Hep3B were
4 or 6 x 106 cells/mL. The final concentration of OMA was 1, 2, or 4 w/v %. The final
concentration of Irgacure2959 was 0, 0.025, 0.05 or 0.10 w/v %. Cells were printed using 
a S+ Microarrayer from ATI Korea (South Korea) into a microwell plate at 640
nL/microwell.
3.2.6. Photopolymerization of OMA
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Photopolymerization was initiated using an Omnicure Series 1500 UV curing 
system from Lumen Dynamics. The light source was fixed 20 cm above the exposed 
surface. The exposed surface was kept at 6oC during the duration of the polymerization to 
prevent sample evaporation. Up to two microwell chips were exposed to near UV light 
during a given exposure. For optimizing polymerization and viability of Hep3B cells in
both OMA-15 and OMA-45, we varied the background color on which the chips rested 
(black cardboard paper versus reflective stainless steel), exposure time (30 seconds to 4 
minutes), exposure intensity (45 versus 70% maximum intensity), PI concentration (up to 
0.10 w/v %), and OMA concentration (1-4 w/v %) with a fixed cell seeding density (4 x 
106 cells∕mL).. For scenarios in which different regions on a microwell chip were exposed 
to different durations of light, the region experiencing shorter exposure was covered with 
black cardboard paper during the extended duration. Additionally, control samples were 
run in 96-well plates without plasma treatment. After polymerization at desired intensities, 
cells were placed in sterile petri plates and immersed in 15 mL pre-warmed complete RPMI
3.2.7. Viability Analysis
Cells were assessed for viability using calcein AM and ethidium homodimer-1 to 
stain for live and dead cells. Microwell chips were initially washed twice in a saline 
solution containing 140 mM NaCl and 20 mM CaCl2 for ten minutes per wash, and dried 
before and after washes by gently blotting with Kimwipes. Each chip was submerged in 8 
mL of D-PBS containing 0.5 μM calcein AM and 0.5 μM ethidium homodimer-1 and
incubated at room temperature in darkness for 2 hours. After washing, microwell chips 
were washed twice again with the saline solution for 20 minutes each in darkness and 
blotted dry using Kimwipes. After the final wash, micropillar chip surfaces were covered
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with a Breath-Easy gas permeable sealing membrane for microtiter plates from Diversified 
Biotech, and subsequently scanned using a S+ Scanner from ATI Korea (South Korea). 
Microwell plates were scanned at a gain of 100 using a green filter. Samples that were not 
immediately scanned were placed in a moist incubation chamber and stored at 4oC until 
scanning could occur. All samples were scanned within 24 hours of the completion of 
staining. Fluorescence intensity was extracted for each layer using an in-house macro 
developed by Yu et. al [141]. Images were filtered of light that fell outside of green 
wavelengths. We then quantified the green fluorescence intensity across an entire image.
3.2.8. Statistical Analysis
Mean, standard deviation, and standard error were calculated in Microsoft Excel.
One-way analysis of variance (ANOVA) was conducted in GraphPad Prism comparing the 
various factors impacting gelation. This analysis was conducted between different 
conditions across the same layer, focusing on the layers with highest cell densities.
3.3. Results
3.3.1. Surface Chemistry for Printing Cells in Microwell Chips
Surface chemistry was assessed by quantifying the percentage of microwells in a 
given chip that containing bubbles after treated chips were immersed in complete media. 
Bubble formation results are shown in Table 4. Ultimately, we found that for our microwell 
chips, bubble formation is minimized while processing plasma at high intensity at a 
pressure of 800-1000 mTorr for 15 minutes. Processing at medium intensity resulted in an
increased amount of bubbles formed in the microwells, as did decreasing the duration of
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the processing. Longer processing at the same intensity and pressure produced no 
noticeable effect on improving the hydrophilicity of the wells in the microwell chips.
Table 4. Bubbles Present in Plasma-Treated Microwell Chips (n=6)
Time
(Minutes)
Area covered with bubbles (%)
Medium RF High RF
5 69.4 ± 1.9 73.8 ±5.3
10 46.6 ±2.8 47.3 ±8.1
15 32.5 ±9.2 14.6 ± 1.4
20 35.5±2.8 20.1 ± 1.5
3.3.2. Effect of Background on Polymerization
Our first attempts at improving OMA polymerization efficiency (and thus, the 
robustness of the 3D system) involved using black and reflective backgrounds while 
maintaining a surface temperature of 6oC. Our initial belief was that a reflective 
background could would provide more energy for more uniform polymerization, but we 
also wanted to test against using a normal lab bench-top color. As a result, background 
color did not impact 3D morphology of the hydrogel, but viability was impacted at 0.1 w/v 
% (Figure 8). We hypothesized that temperature within the microwells could be elevated 
locally due to black background. Since the cooling surface on which the chips sat is made 
of stainless steel, we used a reflective background to potentially increase the energy 
received to initiate photopolymerization. Since both black and reflective backgrounds 
resulted in no differences in the ability to form a gel, we decided to use a reflective 
background for simplicity of future experiments.
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Reflective Background Black Background
Pl Concentration (w∕v %) PI Concentration (w∕v %)
3 Minute Exposure
Black Reflective
6 Minute Exposure
Black Reflective
A B
C
Figure 8. Demonstrated effect of using (A) reflective and (B) black background on the 
viability of Hep3B cells in 2 w/v % OMA-45. Samples were exposed to 0.1-0.3 w/v % PI 
using ~2.5 mW∕cm2 near UV-light for 3-6 minutes and measured at 300 μm above the 
bottom of the well. (C) Images corresponding with graphs at 300 μm above the bottom of 
the microwell (scale bar = 200 μm). Error bars represent SEMs, n = 72.
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3.3.3. Effect of PI
When we examined PI concentration, the viability was optimized around using 0.05 
w/v % Irgacure2959 (Figure 9). Decreasing the PI concentration resulted in decreased 
polymerization efficiency as cells could be observed in 2D. Meanwhile, increasing to 0.1 
w/v % decreased cell viability, and subsequent increases would result in large cell death, 
resulting in a “goldilocks” scenario of using 0.05 w/v % Irgacure2959.
3.3.4. Effect of OMA Concentration
We found that Hep3B cell viability was optimized with 2 w/v % of OMA-45 
(Figure 9). Increasing the hydrogel concentration to 4 w/v % caused numerous problems 
for the cells, including decreased viability and issues with printing due to increased 
viscosity of the materials. In addition, decreasing the concentration of OMA also affected 
the formation of 3D structures, yielding a “goldilocks” scenario of using 2 w/v % OMA- 
45. Furthermore, decreasing the PI concentration to 0.025 w/v % resulted in decreased 
polymerization efficiency while maintaining high cell viability.
3.3.5. Effect of Light Intensity and Duration
With the Irgacure system, we found several conditions that were ideal for 
polymerization of OMA-45 (Figure 10). Using a 45% intensity (~2.5 mW∕cm2) of the 
Omnicure Series 1500 UV curing system, we found polymerization to be achieved with a 
two-minute exposure. At a 70% intensity (~4.0 mW∕cm2), the exposure necessary to form 
gels dropped to 30 seconds. In these cases, subsequent increases of exposure time would 
often result in decreased viability, while decreases of exposure time would result in poor 
gelation, as is the case of with PI concentration. As a result, we decided to use a 70%
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exposure intensity for 30 seconds as we believed this decreased the activation time for the 
PI while also minimizing the effect that changes in temperature could have on sample 
drying.
2 w/v % OMA-45 4 w/v % OMA-45
PI Concentration (w/v %) PI Concentration (w/v %)
A B
2 Minute Exposure
2 % OMA 4 % OMA
4 Minute Exposure
2 % OMA 4 % OMA
C
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Figure 9. Demonstrated effect of varying concentration of OMA and PI using (A) 2 w/v % 
and (B) 4 w/v % OMA-45 on the viability of Hep3B cells. Samples were exposed to 0.025- 
0.1 w/v % PI using ~2.5 mW∕cm2 near UV-light for 2-4 minutes and measured at 300 μm 
above the bottom of the well. (C) Images corresponding with graphs at 300 μm above the 
bottom of the microwell (scale bar = 200 μm). Error bars represent SEMs, n = 72.
3.3.6. Optimization of OMA-15
Our attempts at optimizing photopolymerization while maintaining high Hep3B
viability in OMA-15 in microwell chips proved to be unsuccessful (Figure 11). We found 
polymerization could not be achieved within the microwells for cells grown in OMA-15 in 
a way that would also allow for viable cells. Additionally, we attempted to see if increasing 
the exposure conditions while keeping microwell plates submerged in water to minimize 
temperature increase could aid in polymerization. However, we found that we were unable 
to achieve polymerization of OMA-15 within the microwell chips in this case too. We 
concluded that it is necessary to have methacrylation of 45% (use OMA-45) to achieve 
quick crosslinking at the microscale.
2 w/v % OMA-45 4 w/v % OMA-45
Pl Concentration (w/v %) PI Concentration (w/v %)
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A B
30 Second Exposure
2 % OMA 4 % OMA
60 Second Exposure
2 % OMA 4 % OMA
C
Figure 10. Demonstrated effect of using higher intensity, shorter exposures with (A) 2 w/v 
% and (B) 4 w/v % OMA-45 on the viability of Hep3B cells. Samples were exposed to 0.0- 
0.1 w/v % PI using 4.0 mW∕cm2 near UV-light for 30-60 seconds and measured at 300 μm 
above the bottom of the well. (C) Images corresponding with graphs at 300 μm above the 
bottom of the microwell (scale bar = 200 μm). Error bars represent SEMs, n =72.
2 w/v % OMA-15 4 w/v % OMA-15
PI Concentration (w/v %) PI Concentration (w/v %)
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30 Second Exposure 60 Second Exposure
2 % OMA 4 % OMA 2 % OMA 4 % OMA
C
Figure 11. Comparative results using OMA-15 at (A) 2 w/v % and (B) 4 w/v % hydrogel 
concentration. Samples were exposed to ~ 4 mW∕cm2 intensity light for 30-60 seconds, 
using 0.0-0.1 w/v % PI. Analysis was done for samples at 300 μm above the bottom of the 
microwell. (C) Images corresponding with graphs at 300 μm above the bottom of the 
microwell (scale bar = 200 μm). Erτor bars represent SEMs, n = 72.
3.4. Discussion
The goal of this study was to develop a set of parameters that can polymerize OMA 
for miniaturized tissue cultures to produce viable cells in 3D. We found multiple factors 
that influence this process. While protocols for surface functionalization and etching using 
plasma utilize up to five minutes for treatment [196,197], we found it necessary to treat for 
fifteen minutes to minimize the formation of bubbles. Owing to the fact that microwell 
chips have depressions for containing media and cells, it was necessary to extend treatment
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to ensure that media could adequately enter the wells when the chips were submerged. 
Extending treatment time past fifteen minutes did not decrease hydrophobicity of the chip, 
and changes in intensity of plasma exposure had a saturating effect when treating for longer 
durations. We believe that higher plasma energy was necessary to properly etch the surface 
of the chips, with saturation in the surface treatment having occurred at fifteen minutes. 
Increases or decreases in chamber pressure also tended to result in more bubbles in the 
microwells. We believe that having too little O2 in the chamber means there is insufficient 
surface charge generated, while having too much O2 resulted in decreased gas ionization, 
and thus decreasing the charge on the surface of the microwell chips. While bubbles do 
form within empty chips, bubble formation decreases significantly once 320 nL cell spots 
were printed into the wells. This indicates that we can completely eliminate air bubble 
entrapment by filling up the micro wells (1.5 mm well depth and 1.15 mm well diameter)
with cell spots with plasma treatment, which is critical for long-term cell culture in the 
micro well chip.
When examining polymerization of OMA, background color, PI concentration,
OMA concentration, light exposure duration, light exposure intensity, and the relative 
presence of methacrylate functional groups all effected viability and the ability for Hep3B 
cells to grow in 3D. The results are listed at the top of Table 5 and compared with other 
photo-crosslinked hydrogels. We initially sought to compare black and reflective surfaces, 
along with examining PI concentrations of 0.1 to 0.3 w/v % Irgacure2959. Irgacure2959
was chosen owing to its relatively high solubility in water while requiring low 
concentrations to initiate photopolymerization as compared to other PIs [188]. While 
significant differences were not apparent between black background and reflective
72
background at higher PI concentrations, microwell chips placed on a reflective background 
had cells with greater viability at 0.1 w/v % PI. We suspect that this is due to the effect of 
temperature when the light is exposed, as the black color can absorb the light from the 
source and increase localized heat instead of dissipating it. Since our surface was naturally
reflective and our cells were most viable at 0.1 w/v %, we used these as baselines for
subsequent experiments.
Table 5. Optimized Parameters for OMA Polymerization
Cells
Used
Hydrogel PI Light Ref.
Type Functionali 
zation (%)
Cone.
(w/v %)
Type Conc.
(w/v %)
Intensity I
(mW∕cm2)
Duration
(min)
Hep3B OMA 45 2 Irgacure
2959
0.05 2.5-4.0 0.5-2 N/A
hMSC
s
OMA 15 2 Irgacure
2959
0.05 1 10 [198]
Chond
rocytes
OMA 45 2 Irgacure
2959
0.05 1 10 [181]
hADM
SCs
GelMA 80 6 Irgacure
2959
0.05 2 5 [199]
VA086 0.75
MDA
MB
231s
GelMA 80 10 Irgacure
2959
0.05 1 10 [99]
VICs GelMA 94 15 Irgacure 0.5 7.2 0.25 [200]
2959
Abbreviations: human mesenchymal stem cells (hMSCs); human adipose-derived MSCs 
(hADMSCs); methacrylated gelatin (GelMA); MD Anderson metastatic breast 231 (MDA 
MB 231) cancer cells; aortic valvular interstitial cells (VICs);
Results indicated that PI concentration significantly affected viability to the extent 
that subsequent experiments required using 0.1 w/v % PI as an upper limit to the 
concentration. We believe that the decrease in viability was due to the formation of the
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radicalized PI via the UV light in such heavy quantities that subsequent generation of 
radicals caused oxidative damage to the cells. Using 0.1 w/v % PI was even shown to be 
toxic to cells as compared to 0.025 and 0.05 w/v % when accounting for fluctuations in 
light intensity and duration. We ultimately decided to use 0.05 w/v % PI, as this gave us 
consistent results in both cell viability and polymerization of OMA. We believe this is due 
to the “goldilocks” scenario achieved where at 0.05 % w/v, the concentration of PI is high 
enough where the radicals formed from the light can initiate sufficient polymerization of 
OMA, but not at such high concentrations that cause significant oxidative stress to the cells.
Regarding OMA concentration, our results clearly indicate that using higher 
concentrations of OMA (4 w/v %) resulted in decreased cell viability. This result indicates 
that high crosslinking with high concentrations of OMA (typically above 2 w/v %) is 
cytotoxic and may lead to diffusion limitations of nutrients and oxygen. We believe the 
high concentration of OMA impacted viability as the presence of too many cross-linking 
sites limited the ability of the Hep3B cells to thrive. Generally, divalent cation-polymerized 
alginate can be used at lower percentages than OMA because the cross-linking density is 
enough to support 3D cell growth while not so large as to restrict it or have a toxic effect 
on the cells [91,136]. Simply using 2 w/v % instead of 4 w/v % allowed us to maintain 
high cell viability without compromising the ability of OMA to be polymerized in the 
microwells. This result was consistent regardless of the exposure conditions used to initiate 
polymerization. An additional benefit of using 2 % w/v instead of 4 % w/v OMA is the 
decreased solution viscosity, which was generally easier to handle manually and is easier 
to print with our robotic dispensing system (S+ Microarrayer). Other groups also found
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that use of lower concentrations of OMA were also favored for better cell viability
[181,198].
The major variations between macro- and micro-scale photopolymerization are due 
to the effects of light exposure such as the duration and intensity of light. The penetration 
depth of light would be up to ten times different between macro- and micro-scale 
photopolymerization (1 cm vs. 1 mm). In the case of the exposure conditions, we were able 
to achieve successful photopolymerization of OMA while optimizing viability of Hep3B 
under at least two conditions. Both relatively short duration, higher intensity light and 
longer exposure, lower intensity light yielded optimal results while polymerizing 2 w/v % 
OMA with 0.05 w/v % PI. While the light is necessary for photopolymerization, activation 
of radicals and temperature increase both occur as a result of using this light source. 
Temperature is highly tied to both intensity and duration of light, as increasing either of
these variables increased the ambient temperatures to above 38oC. In the case of PI,
polymerization becomes active in the presence of near UV-light, so increases in intensity 
and duration resulted in increased concentration of radicals and subsequent oxidative stress 
to the cells. Our results were similarly reflected by Chen et al who initiated GelMA 
polymerization in a microfluidic device, and found that shorter duration, higher intensity 
exposure was better suited for forming 3D hydrogels at smaller scales [200].
In addition, the relative presence of methacrylate groups in OMA was also a major 
factor in polymerization efficiency in the microwell chip. Despite trying numerous
combinations of factors affecting polymerization we were unable to achieve 3D culture in 
OMA-15 in the microwell chip. We believe the reason for this is that with fewer sites for 
crosslinking, the ability to form a gel within the microwell is limited. Increasing
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concentration of OMA resulted in cell death, while decreased concentration still resulted
in a lack of polymerization of OMA-15. All of this occurred independent of PI
concentration and parameters affecting exposed light. Polymerization within the microwell 
chip is somewhat hampered compared to on glass slides or other smooth surfaces, as the 
intensity of light experienced at the bottom of the well is effectively 25-30 % less than that 
experienced at the top of the well. This necessitates increasing exposure intensity or 
duration to generate enough radicals for polymerization without impacting cell viability. 
While this may not limit the ability of OMA-15 to be used as a hydrogel for microscale 
tissue culture, it does mean that low methacrylate concentration within the OMA may not 
be polymerized effectively in small volumes with relatively low exposed surface areas. As
a result, OMA-15 cannot be used for microscale tissue culture in such situations (i.e.,
within our microwell chips).
While microwell chips are an improvement compared to micropillar chips in terms
of recapitulating 3D cell behavior, there are several drawbacks. One issue is that because 
microwell chips require submersion in petri plates to sustain sufficient nutrient growth, 
microwell chips cannot be used in combinatorial studies for testing drug efficacy or toxicity 
Additionally, media can only enter through the top of the well, so there is the potential for
nutrient diffusion limitation issues to cells located near the bottom of the well.
3.5. Conclusions
We were able to successfully create viable 3D-cultured Hep3B cell structures 
within microwell chips using a photopolymerizable hydrogel, OMA-45. While the material
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parameters of 0.05 w/v % Irgacure2959 and 2 w/v % OMA-45 concentration and 
methacrylate concentration work to produce viable cells encapsulated in strong hydrogels, 
polymerization is best achieved using 4.0 mW∕cm2 intensity light for 30 seconds or 2.5 
mW∕cm2 light for two minutes. There is a significant contribution to the ability to form 
viable 3D spheroids from the size of the reaction and the apparatus, as OMA-15 could not 
be polymerized in microwell chips. Additionally, larger scale polymerizations generally
require lower intensity and significantly longer durations of exposure, while microscale 
polymerizations benefit from higher intensity and quicker reactions. Ultimately, these 
results are promising for generating miniaturized tissue constructs within the microwell 
chips. In the future, we hope to use OMA-45 as a hydrogel scaffold for full recapitulation 
of the in vivo liver functions and to create a model for observing specific liver disease states
in vitro.
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CHAPTER IV
A HIGH-THROUGHPUT 3D HEPATIC CANCER CELL MIGRATION ASSAY
ON A 384-PILLAR PLATE WITH SIDEWALLS
4.1. Introduction
Hepatocellular carcinoma (HCC) is the most widely distributed liver cancer in the 
world, constituting about sixty five percent of liver cancer patients, and it is the sixth most 
prevalent of all cancers globally [4]. HCC, unlike other cancers in the United States, is 
seeing an increase of incidence, with estimates placing the number of affected individuals 
having tripled since the 1980s [1,5]. These triggers are likely due to the fact that poor 
sanitation conditions have seen an increase in individuals infected with hepatitis, where the 
hepatitis B and hepatitis C viruses (HBV and HCV respectively) are known to lead to HCC 
[1]. HCC is characterized by generally being treatable if detected early but having poor 
prognosis during later staging of the disease if metastasis has occurred [31,36]. Thus, it is 
the goal of scientists and doctors to understand what causes metastasis of HCC, how to 
prevent the spread of the disease, and how to better treat a patient who is experiencing
metastasis.
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Cancer metastasis can be triggered by external cues, signaling cells to migrate away 
from the initial tumor site towards otherwise unaffected parts of a previously affected organ 
or to different organs entirely [59]. The nature of these cues is diverse, ranging from 
changes in confirmation of the extracellular matrix (ECM) in the tumor, to small and large 
molecule signaling from lack of nutrients [59,201]. The tumor ECM plays a large role in
the metastasis of a cancer, as tumors are generally poorly vascularized, and have a much 
more heterogeneous cell distribution than a healthy tissue [6,202]. Once angiogenesis 
within the tumor occurs, the cells from the HCC have a means from which to migration out 
[6,203]. Often, these markers for angiogenesis are triggers for metastasis in themselves
[204-206].
Because of the variety of biomarkers and triggers for cancer metastasis, scientists 
desire methods to mete out any false positives for cancer detection and determine how
these various factors interact with each other. Growth factors (GFs) such as basic fibroblast
growth factor (bFGF) and transforming growth factor beta 1 (TGFβl) play important roles 
in cellular reorganization, but also in angiogenesis as signal molecules for cancer cell 
metastasis [60,207-209]. Due to the variant nature of cancer, it is important for scientists 
and doctors to know the distinct molecules that can signal for metastasis based on the type
of cancer and the individual case.
Often, scientists will use cell migration studies as an in vitro assessment of potential 
metastatic cues. General migration tests have focused on two-dimensional (2D) 
assessments, such as wound healing assays, to signal and promote cell movement [47,210]. 
However, 2D migration systems lack the directionality of movement associated with true 
metastatic behavior observed in vivo [47,56]. Additionally, media supplementation to these
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systems cannot mimic the nutrient transport observed in a three-dimensional (3D) in vivo 
environment [205,211]. 3D cell migration has focused on developing cell spheroids and 
quantifying the dispersal of cells away from spheroids or tracking individual cell 
movement through ECM mimics [47,56,212]. The main draw back with using 3D systems
is that it is trickier to determine modes of migration, particularly in high-throughput when 
numerous factors need to be considered for understanding the nature of a tumor [47,68,212]
Our group has previously developed several small-scale high-throughput platforms, 
mostly used in the development of drug toxicity testing. Originally, we worked with the 
micropillar chip for cell culture and paired with a microwell chip containing media and
various dissolved compounds [ 142,143,213,214]. Because of the size limitations 
associated with micropillar chip cultures, adequate 3D cell cultures could not be generated. 
We subsequently used microwell chips as the platform for cell seeding while immersing 
the chips in media in petri plates. While this allowed a better recapitulation for certain cell 
culture aspects, the microwell chip is not ideal for combinatorial work as media 
composition cannot vary between wells on the same chip due to the need to immerse whole 
chips in individual petri plates to supply sufficient nutrients to cells. Additionally, cells 
located within a microwell chip beneath several other layers of cells could suffer from lack 
of nutrients. The current system developed by Bigdelou et. al. utilizes pillar plates designed 
with sidewalls fitted to a 384-well plate (Unpublished). Here, cells encapsulated in 
hydrogels would grow on the pillars while being supported by the sidewalls beneath the 
pillars. The sidewalls can help anchor cell droplets, while the spaces between the walls 
allow for nutrients from growth media to come into contact with cells on the pillar. The 
sidewalls can hold about 4 μL of hydrogel droplet volume, which is sufficient for several
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layers of printed cells. Because the platform is designed to be paired with a 384-well plate, 
combinatorial studies can be conducted using varied growth media, making it ideal for 
understanding the multitude of factors affecting cancer cell migration.
The goal of this work is to develop a high-throughput 3D cancer cell migration test. 
In order to do this, we will let cells migrate in response to the presence of various growth 
factors and extracellular matrix (ECM) components within the 384-pillar plate with 
sidewalls (Figure 12). We used oxidized methacrylated alginate (OMA-45) for cell 
encapsulation. The use of OMA-45 for microscale polymerization has been optimized as 
detailed in Chapter III, while the design of the 384-pillar plate with sidewalls was 
optimized by Bigdelou et. al. (unpublished). The design of the test is similar to a typical 
sandwich assay. On the first-printed layer, we print OMA with various growth factors 
which will be stabilized with the presence of methacyrlated heparin sulfate (MHS). On the 
second layer, we will print cell-laden OMA. The Hep3B cells used in the top layer will 
have been infected with lentiviruses containing mCherry expression so that we can monitor 
in real time if cells are migrating in response to the materials in the bottom layer. Cells will 
be monitored for up to two weeks to determine if migration occurs in response to the 
presence of certain chemoattractants by taking pictures of the cells at various heights within 
the pillars. Finally, this migration will be quantified using developed in house macros 
which will filter out any background associated with out-of-focus cells. This will ultimately 
give us a method in which we can quantify 3D cell migration in high-throughput.
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384-pillar plate with sidewalls
Growth factors Hep3B cells in Media in 384- 
in OMA and OMA(2μL) well plate 
Heparin (2 μL)
Cells migrating in response to 
growth factors
C
Figure 12. (A) Schematic representation of 384-pillar plates with sidewalls. (B) A 
photograph of a 384-pillar plate with sidewalls. (C) Schematic representing migration 
assay in 384-pillar plate with side walls. Initially, growth factors are bound to heparin 
sulfate and encapsulated with OMA. Then, cells are encapsulated in OMA and printed on 
a second layer. This is inverted and stamped into a 384-well plate, where cells migrate in 
response to growth factors.
4.2. Materials and Methods
4.2.1. Materials
Hep3B human hepatoma cell line (catalog no. HB-8064), HEK293T cells (catalog 
no. CRL-11268) and all cell culture ingredients, including RPMI, DMEM, fetal bovine
serum (FBS), penicillin-streptomycin (PS), and gentamicin were provided from ATCC.
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The microwell chips were manufactured by MBD Korea (Suwon, South Korea). Staining 
solutions, including calcein AM and ethidium homodimer-1, Opti-MEM reduced serum 
media (31985062), and lipofectamine 2000 (11668027) transfection reagent were 
purchased from ThermoFisher. 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone 
(trade name, Irgacure-2959, 410896) for photopolymerization, polybrene infection/
transfection reagent (TR-1003-G), and heparin sodium salt from porcine intestinal mucosa 
(H3393) was obtained from Sigma Aldrich. The growth factors basic fibroblast growth 
factor (bFGF, cyt-218), hepatocyte growth factor (HGF, cyt-244), transforming growth 
factor beat (TGF-β, cyt-716), and vascular endothelial growth factor (VEGF, cyt-241) were 
all sourced from ProspecBio. The VEGF ELISA kit (DY293B-05) and the ancillary reagent
kit (DY008) were sourced from DuoSet. E-Shell 450 Clear M (RES-02-422) from
EnvisionTEC was used to create the initial mold for the printed 60-pillar plate with side 
walls described in Bigdelou et al (Unpublished) before the optimized 384-pillar plate with 
sidewalls manufactured via plastic injection molding at TechOne.
4.2.2. Synthesis of OMA
OMA-45 was prepared by the previously reported method with modification by Dr. 
Jeon and Dr. Alsbserg of Case Western Reserve University [181,189]. Briefly, sodium 
alginate (10 g, Protanal LF 20/40, FMC Biopolymer) was dissolved in ultrapure deionized 
water (diH2O, 900 ml) overnight. Sodium periodate (1 and 1.75 g, Sigma) was dissolved 
in 100 ml diH2O, added into separate alginate solutions under stirring to achieve 10 and 
17.5 % theoretical alginate oxidation, and allowed to react in the dark at room temperature 
for 24 hrs. The oxidized, methacrylated alginate (OMA) macromers were prepared by 
reacting OA with 2-aminoethyl methacrylate (AEMA). To synthesize OMA, 2-
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morpholinoethanesulfonic acid (MES, 9.76 g, Sigma) and NaCl (8.765 g) were directly
added to an OA solution (500 L) and the pH was adjusted to 6.5. N-hydroxysuccinimide 
(NHS, 0.44 and 1.325 g, Sigma) and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide
hydrochloride (EDC, 1.46 sand 4.375 g, Sigma) were added to the mixture under stirring 
to activate 45 % of the carboxylic acid groups of the alginate. After 5 min, AEMA (0.635 
and 1.9 g, Polysciences) (molar ratio of NHS:EDC:AEMA = 1:2:1) was added to the
solution, and the reaction was maintained in the dark at RT for 24 hrs. The reaction mixture
was precipitated into excess of acetone, dried in a fume hood, and rehydrated to a 1 % w/v 
solution in diH2O for further purification. The OMA was purified by dialysis against diH2O 
using a dialysis membrane (MWCO 3500, Spectrum Laboratories Inc.) for 3 days, treated 
with activated charcoal (5 g/L, 50-200 mesh, Fisher) for 30 min, filtered (0.22 μm filter) 
and lyophilized.
4.2.3. Cell Migration in Microwell Chips
We initially tested migration using microwell chips, with a Matrigel-OMA bottom 
layer and a top layer of OMA. Microwell chips were exposed to plasma using a PDC-001- 
HP high power expanded plasma cleaner from Harrick Plasma. Samples were processed 
for 15 minutes at high intensity. 120 mg OMA-45 was dissolved in 2 mL complete RPMI
to a concentration of 6 w/v %. 100 mg PI was dissolved in 1 mL 70 v/v % ethanol to a 
concentration of 10 w/v %. 80 μL OMA was added to 1.2 μL PI with variable amounts of 
9.1 mg/mL Matrigel and complete media to a final volume of 240 μL. The final
concentration of the bottom layer of solution consisted of 2 w/v % OMA-45, 0.05 % w/v 
PI, and 0, 1,2, 3, or 4 mg/mL Matrigel, all diluted in complete RPMI. Additionally, a 
control was run that contained 0 mg/mL Matrigel and 0 % w/v PI. The bottom layer was
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printed with an S+ Microarrayer at 320 nL/microwell and gelled using the Omnicure 1500S 
system at 4 mW∕cm2 for 30 seconds. We then combined 600 μL OMA-45, 9 μL PI, 900 μL 
8 x 106 cells/mL, and 291 μL complete RPMI to form the top layer, which consisted of 2 
w/v % OMA-45, 0.05 w/v % PI, and 4 X 106 cells/well. The top cell layer was printed on 
top of the Matrigel bottom layer at 320 nL/well, and gelled using the Omnicure 1500S 
system at 4 mW∕cm2 for 30 seconds. Cells were submerged in 15 mL media in petri plates, 
where media was changed as needed. Microwell chips were removed 0, 3, 7, and 14 days 
after initial print for cell staining.
4.2.4. Cell Staining
Cells were assessed for viability using calcein AM and ethidium homodimer-1 to 
stain for live and dead cells. Microwell chips were initially washed twice in a saline 
solution containing 140 mM NaCl and 20 mM CaCl2 for ten minutes per wash, and dried 
before and after washes by gently blotting with Kimwipes. Each chip was submerged in 8 
mL of D-PBS containing 0.5 μM calcein AM and 0.5 μM ethidium homodimer-1 and
incubated at room temperature in darkness for 2 hours. After washing, microwell chips 
were washed twice again with the saline solution for 20 minutes each in darkness and 
blotted dry using Kimwipes. After the final wash, micropillar chip surfaces were covered 
with a Breath-Easy gas permeable sealing membrane for microtiter plates from Diversified 
Biotech, and subsequently scanned using a S+ Scanner from ATI Korea (South Korea). 
Microwell plates were scanned at a gain of 100 using a green filter. Samples that were not 
immediately scanned were placed in a moist incubation chamber and stored at 4oC until 
scanning could occur. All samples were scanned within 24 hours of the completion of 
staining. Fluorescence intensity was extracted for each layer using an in-house macro
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developed by Yu et. al [141]. Images were filtered of light that fell outside of green 
wavelengths. We then quantified the green fluorescence intensity across an entire image.
4.2.5. Surface Treatment of 384-Pillar Plates with Sidewalls
384-pillar plates were sandwiched with 384-well plates containing 30 μL∕well 0.05
% w/v PMA-OD and left to dry under ambient air at room temperature for 2-3 hours. The 
pillar plates with sidewalls were then sandwiched with 384-well plates containing 30 
μL∕well 0.0033 w/v % PLL solution and left to air dry over night before printing.
4.2.6. Growth Factor Leaching
Initially, 120 mg of OMA-45 was dissolved in 2 mL complete RPMI (RPMI + 10 %
v/v FBS, 1 % v/v PS, and 0.1 % v/v gentamicin) using a metal spatula, then vortexed and 
centrifuged at 500 g for 5 minutes. If precipitate was present, this process was repeated 
until the precipitate was gone. For heparin-dependent leaching, we added 12 mg of heparin 
to the 120 mg OMA-45 before adding the media. This yielded a 6 % w/v OMA-45 and 0.6 
% w/v heparin solution. We diluted 10 μL of the VEGF in 500 mM NaCl to form a 40 
μg∕mL solution of VEGF. We then combined 133.3 μL of our OMA with 2 μL of 10 %
w/v PI in 70 % ethanol and 214.7 μL complete RPMI as our stock solution. 35 μL of the 
stock solution was combined in separate tubes with 0-5 μL of the 20 μg∕mL VEGF solution 
and finished off with 0-5 μL media. This yielded a 2 % w/v OMA-45 hydrogel (with
possible 0.2 % w/v heparin), and 0.5 μg∕mL bound VEGF and 0.05 % w/v PI in a total 
volume of 40 μL. Samples were manually pipetted into the depression of the 384-pillar 
plate with sidewalls at 2 μL∕pillar. Samples were then exposed to UV-light from using an 
Omnicure Series 1500 UV curing system from Lumen Dynamics. Exposure occurred at 20 
cm beneath the light source at 12 cm above the plate for 60 seconds. For the top layer, we
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combined 133.3 μL 6 % w/v OMA-45, 2 μL 10 % w/v PI in 70 % ethanol, and 264.7 μL
complete RPMI to form a final solution of 2 % w/v OMA-45 and 0.05 % w/v PI in a total 
volume of 400 μL. 2 μL were added to the same wells our VEGF-containing samples were 
mixed in and re-exposed to the UV light at the previously described conditions. The top 
layer was printed at 2 μL∕pillar on top of the growth factor layer in the 60-pillar plate with 
sidewalls using a S+ Microarrayer. Samples were re-exposed to light at the previous 
described conditions. Samples were then immersed in 50 μL complete RPMI in a 384-well 
plate. All the media in the wells was taken out and replaced with fresh media at 1, 4, 8, and 
24 hours, followed by media replacement every other day starting at day 2 until day 14. 
Samples were frozen until analysis of leaching was performed.
4.2.7. Quantifying the Leach Concentration
Leached VEGF was quantified using a VEGF ELISA kit from DuoSet. Capture 
antibody was coated overnight at room temperature in a 96 well plate. Wells were washed 
three times with tween-20, then exposed to 300 μL∕well BSA blocking solution for one 
hour. Wells were washed again three times before exposure to samples and standards (15.6- 
1000 pg∕mL). Samples were incubated for another two hours and washed three times again. 
Samples were exposed to the capture antibody at room temperature for two hours. Samples 
were washed again then exposed to strep-HRP for 20 minutes. Wells were washed three 
times again and exposed to two color reagents. The reaction was stopped after 20 minutes, 
and absorbance measurements were taken at 450, 540, and 570 nm immediately.
4.2.8. Design and Expansion of Lentivirus Vector
The lentivirus was designed and expanded using the protocols of Joshi et al. 
(Unpublished). HEK293T cells (passage < 10) were expanded to 50 % confluence in
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DMEM + 10 v/v % FBS + 1 v/v % PS in a T-25 flask. In one tube, 200 μL Opti-MEM
reduced serum media was mixed with 16 μl lipofectamine 2000 reagent. In a second tube, 
266 μL opti-MEM reduced serum media was mixed with 30 μL pLV-mCherry vector (40 
ng∕μL), 1 μL pMDG2 (800 ng∕μL), and 2 μL pSOX2 (800 ng∕μL). The contents of the two 
vials were mixed to a total volume of 525 μL with 2.28 ng∕μL pLV-mCherry, 1.52 ng∕μL
pMDG2, and 3.05 ng∕μL pSOX2. Media was removed from the flask and cells were 
washed before this solution was added with 2 mL DMEM +10 v/v % FBS and 2.5 μL 10 
mg/mL polybrene to assist in transfection and incubated for one day at 370C and 5 % CO2, 
after which transfection was observed at > 90%. Subsequently, supernatant was collected
and 2.5 mL fresh DMEM + 10 v/v % FBS + 1 v/v % PS was added, and cells were
continually incubated for another three days. The supernatant was collected again and 
pooled with the supernatant collected at day 1 and stored at -80 oC until further use. 
Samples were concentrated using centrifugal filtration and titered using FACS.
4.2.9. Transduction of Lentiviruses into Hep3B Cells
1 * 106 Hep3B cells (Pl5-30) were plated on a T-25 flask and grown in 5 mL RPMI
+ 10 % FBS + 1 % PS for 48 hours, or until 50-60 % confluence was reached. Media was
removed and replaced with 2 mL antibiotic-free RPMI + 10 % FBS, 40 μL lentivirus stock 
solution, and 2.5 μL 10 mg/mL polybrene for a multiplicity of infection (MOI) of 1. Cells 
were grown in the flask for 24 hours before addition of 5 mL RPMI + 10 % FBS. These
cells were grown for another 24 hours before passaging and expansion. Cells were frozen 
at -80oC for future experiments.
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4.2.10. Cell Migration with Encapsulated Growth Factors
For cell migration, we followed a similar protocol to our leach experiment. OMA 
and heparin were dissolved in complete RPMI at 6 and 0.6 % w/v respectively using a 
combination of manual stirring and vortexing, then centrifuging at 500 g for 5 minutes to
remove bubbles. Next, samples were combined with 10 % w/v PI in 70 % ethanol, 
individual growth factor solutions (stock concentration: 200 μg∕mL), and complete RPMI. 
All growth factors (TGFβl, VEGF, bFGF, and HGF) were printed at a final concentration 
of 1 μg∕mL, with OMA and heparin at 2 and 0.2 % w/v respectively, and PI at 0.05 % w/v. 
Samples were incubated for three hours at room temperature before being dispensed on the 
384-pillar plate with side walls at 2 μL∕pillar using a S+ Microarrayer. Samples were then 
polymerized via exposure to near UV-light at 70% intensity 12 cm above the plate for 60 
seconds. The top layer was then prepared, combining 120 μL of 8 * 106 infected Hep3B 
cells/mL, 80 μL 6.0 % w/v OMA-45 in complete RPMI, 1.2 μL 10 % w/v PI in 70 % 
ethanol, and 38.8 μL RPMI. This gave us a final concentration of 4 * 106 infected Hep3B 
cells/mL in 2.0 % w/v OMA-45 and 0.05 % w/v PI. This top layer was printed at 2 μL∕well 
using a S+ Microarrayer. After the top layer was printed, cells were allowed to settle for 
five minutes before being polymerized by near UV-light. Cells were imaged at seven 
different positions spaced 250 μm apart, starting from the top edges to the side wall until 
hitting the pillar surface daily for two weeks after seeding. Images were taken using a S+ 
Scanner with an orange filter (SEMCO, TxRed-4040C-000) using 100 and 400 gain at on
day zero with decreasing the high gain until day 14 was reached, when 25 gain was used.
89
4.2.11. Quantification of Cell Migration
We developed a macro through which we eliminated out-of-focus cells first. The 
macro developed in Image J would have images undergo a finite Fourier transform (FFT), 
with bandpass filtering at 50 and 250 Hz before undergoing inverse FFT (iFFT). Finally,
the macro would sorted into folders containing common z-positions based on labels within 
the file names. Next, fluorescence was quantified using an in-house developed bioprinting 
macro for ImageJ that quantifies the range of fluorescence between 0 and 50 to only 
quantify the red signal. After the signal was quantified, we calculated the mean position of 
the cells using the following equation:
Where Z is the mean position of the cells, f and zi are the corresponding fluorescence
intensity and z-position height in row i. We then calculated a rate of cell movement by 
comparing mean z-positions in identical wells across various time points.
4.2.12. Statistical Analysis
Mean, standard deviation, and standard error were calculated in Microsoft Excel.
One-way analysis of variance (ANOVA) was conducted in GraphPad Prism comparing the 
individual and combinations of growth factors in the gel and in solution. Graphs for ELISA 
standards, fluorescence intensity, leaching, and migration were generated in SigmaPlot.
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4.3. Results
4.3.1. Migration in Microwell Chips
The quantification of migration showing mean position in the wells of the 
microwell chips is shown in Figure 13. We were able to successfully distinguish cells 
between layers using our macro and observed some cell movement. However, much of this 
movement was limited, and none of our results showed chemoattraction towards Matrigel. 
Additionally, because our procedure required staining of the cells, samples had to be 
disposed after imaging and could not be used for subsequent monitoring of migration, 
which forced us to use Hep3B cells infected with lentiviruses to track migration.
4.3.2. Lentivirus Transduction
The results of lentiviral transductions are shown in Figure 14. We were able to 
successfully transduce lentiviruses into cells. Efficiency of transfection was estimated 
around 80 percent. Furthermore, infected Hep3B cells were successfully frozen and thawed 
after infection with the virus. There was no significant impact with viability on the cells, 
and cells retained expression of mCheιτy up to ten passages after the frozen cell line was 
thawed. Thus, we were able to create a stable Hep3B cell culture capable of expressing 
mCherry for the purposes of tracking migration.
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Figure 13. A) Calcein-AM stained Hep3B cells encapsulated in 2 w/v % OMA-45 and 
printed into a microwell chip on the top layer, with the bottom layer for this set of images 
containing 1.5 mg/mL Matrigel. Scale bar = 200 μm. B) Average position of Hep3B cells 
within the microwell chip measured as distance from the bottom of the well based on our 
process described in section 4.2.11. Error bars represent SEMs, n = 72.
4.3.3. Growth Factor Leaching
The results of our leaching indicate that we were able to observe leaching effects 
primarily within the first 24 hours that slowly increased over time (Figure 15). Moreover,
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growth factor leaching was greater without MHS continuously, and was completely 
released by four days after printing, though the rate of release seemed to dissipate after the 
first day. Samples bound to MHS had a slower, but continual release profile. This linear 
release is consistent with literature values for growth factor release studies for heparin 
sulfate-bound samples [215,216]. Thus, our results indicate the need for MHS to stabilize 
growth factors in hydrogels.
Figure 14. 2D cells infected with lentiviruses containing expression for mCherry 2D 
images on a 96 well plate of cells 15 passages after transduction. Scale bar = 200 μm.
Early Release Delayed Release
A B
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Figure 15. Analysis of the leaching of 1 μg∕mL bFGF from OMA-45 either mixed with 
0.2 w/v % heparin or no heparin A) within the first 24 hours of immersion B) for the 
duration of the experiment. Error bars represent SEMs, n = 12.
4.3.4. Cell Growth in 384-Pillar Plates with Sidewalls
The results of our cell growth experiments are shown in Figure 5. As it can be seen, 
cells successfully proliferated for up to two weeks after the initial print, though it was hard 
to quantify differences in fluorescence intensity in significantly proliferated samples after 
day 6 due to the saturation in fluorescence at 100 gain after day 6. It is hard to give an exact 
cell count with this procedure, given the nature of spheroid formation potentially 
amplifying or impeding red signals. Samples were initially rather dark on day 0 owing to
the fact that after infected Hep3B cells are passaged, mCherry expression subsequently 
decreases and takes time to recover, which likely results in underestimating the actual cell 
number on day 0. The samples that proliferated the most were all, HGF, and TGFβl. 
Furthermore, we observed spheroid cultures forming within the plate, indicating that our 
platform is suitable for long term 3D culture. Spheroid generation seemed to increase with 
time and start forming 4-6 days after the initial print for all conditions regardless of the 
presence of growth factors. Fluorescence intensity of infected cells increased with time up 
to about six days after seeding indicating that the infection also has long term stability in 
3D culture and can be used to monitor the cells. Additionally, spheroid cultures formed 
readily here unlike in microwell chips where cells seemed to proliferate though with limited 
growth potential. This shows that the 384-pillar plate with sidewalls is better for long-term 
sustenance of cell growth and mimicking the HCC tumor architecture than microwell chips. 
One drawback is the formation of bubbles that can occur between layers, which somewhat 
hampered our ability to monitor migration and adequately quantify fluorescence.
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Conditions which seemed to cause the greatest formation of spheroids were cells in the 
presence of HGF and the combination of growth factors. This proliferation is reflective of 
the effect this growth factor has on the cells in vivo. Other growth factors did not induce 
the formation of spheroids as compared to the absence of growth factors.
A
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BFigure 16. A) Representative images of Hep3B cells expressing mCherry in a 384-pillar 
plate with sidewalls after being exposed to various growth factors for up to two weeks. 
Images were taken 500 μm away from the pillar surface Scale bar = 200 μm. B) 
Fluorescence intensity changes as a function of time. For fluorescence intensity, this 
reflects the total fluorescence observed summed over all z-positions. Error bars represent 
SEMs, n= 12.
4.3.5. Migration in 384-Pillar Plates with Sidewalls
The results of our migration experiments in 384-pillar plates with sidewalls is
shown in Figure 17, with rates of migration discussed in Table 6, with deviations in 
linearity denoted by root square mean (R2). All conditions were found to have an average 
initial position between 740 and 750 μm from the pillar surface, which is consistent with
where the start of the second layer should be given the area between the sidewalls. We 
found some levels of migration to be promoted with VEGF, bFGF, TGFβl, and
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combinatorial growth factors, while HGF did not seem to induce migration relative to 
controls. Most of this migration seemed to take place later in the assay, though error was 
significantly large at individual time points to show no individual deviations between 
samples at individual time points. Even still, the trends for movement towards the layer 
with printed growth factors and against gravity were apparent. In all cases, there was some 
movement towards the first printed layer, particularly later in the assay. HGF and control 
samples showed relatively little migration. We were able to distinguish spheroid formation 
vs. migration by eliminating out of focus cells using our developed in-house macro, which 
eliminates low and high frequencies after undergoing FFT. Migration potential was 
greatest in the case of VEGF, followed by combinations of growth factors used. bFGF, 
VEGF, and combination growth factor used generally showed migration moving in the 
direction of growth factors, while TGFβl exposed samples did not necessarily follow the
same continue trend.
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Figure 17. Relative average position of cells in the presence of growth factors as a function 
of time. Note: 500 μm from the pillar surface represents the distance beneath the pillar 
surface, meaning decreases in height represent movement of cells against gravity. Error 
bars represent SEMs, n = 12.
Table 6. Average Cell Migration as a Function of Growth Factor
Exposed Growth 
Factor
Average Cell 
Movement (μm∕day) R2
None -3.96 0.74
bFGF -10.42 0.67
TGFβl -8.01 0.41
VEGF -11.68 0.61
HGF -2.73 0.34
All -10.73 0.84
4.4. Discussion
In this work, we created a high-throughput cancer cell migration assay. To perform 
this study, we combined several different engineering designs, including the creation of a 
fluorescent lentivirus for subsequent transfection in a cell line to make permanently 
fluorescence Hep3B cells, synthesized a chemically modified version of alginate that is 
photopolymerizable, engineered a platform capable of supporting 3D cell-culture that is 
compatible with other high-throughput technologies, and developed our own image 
processing capabilities to fully analyze cell migration. Integrating these engineering 
strategies creates a platform through which 3D cell migration and cell proliferation can be 
monitored in real-time and in high throughput for up to two weeks after initial cell seeding.
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Initially we attempted to study migration in a microwell chip using calcein and 
ethidium stains. This protocol was based on previous work performed in Chapter III where 
we optimized OMA viability and polymerization in microwell chips. While cells were 
viable out to two weeks, growth seemed to be static within the microwell chips as compared 
to the 384-pillar plate with sidewalls. We suspect this is due to potential nutrient 
deprivation experienced by cells within the microwells, as we successfully generated 
spheroid culture within the 384-pillar plate with sidewalls. The design of the microwell 
chips allows for nutrients to diffuse through one surface: the top interface between the 
hydrogel and the cell culture media. Cells further from this surface are less likely to see 
any nutrients and oxygen, meaning there are diffusion limitations to their growth. This is 
not a problem in the 384-pillar plate with sidewalls, as the slits between the sidewalls give 
encapsulated cells more access to nutrients.
While spot detachment has been an issue with a previously designed 384-pillar 
plate and micropillar chips, the combination of surface modifications our group previously 
developed and the capillary forces within the depression in the pillar serve to anchor the 
hydrogel to the pillar. Bubble formation was somewhat of an issue with printing as the 
nozzles with our machine are designed to print smaller volumes that 2 μL droplets, and 
bubbles could also get trapped between printed layers. Additionally, bubbles within the 
media in 384 well plates could be trapped within the pillars, so care needs to be taken when 
media is dispensed into the 384-well plate.
Hep3B cells were successfully transduced with lentivirus containing mCherry at 
about an 80-90 % transduction efficiency. Moreover, the lentivirus expression was stable, 
as cells passaged ten times after transduction still expressed mCherry. The expression of
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the lentivirus was optimal about 3-4 days after passaging when cells reached 80-90 % 
confluence on the T-flask. We believe that the reason for this is that as cells are passaged, 
cell surface proteins are affected, which diverts much of the cells’ energy towards 
processes to ensure their survival. This result is consistently reflected in our 
migration/growth studies, where samples at day 0 produced relatively little fluorescence 
that was only observable after two days growth. After cells are passaged, they are more 
likely to proliferate in either 2D or 3D conditions, which explains why this expression is
stronger days after passaging. Moreover, the use of lentivirus transduced cells allows us to 
monitor cell movement in real time without disposing our samples. With calcein-stained 
samples, cells had to be disposed of after staining due to the degradation of the fluorophore 
over time and the toxicity associated with increased exposure to the fluorophore. This 
means that only end-point monitoring of migration could be performed with stained 
samples, so migration could not be accurately assessed with the stained samples.
We were able to successfully encapsulate growth factors within OMA for slow 
release for our migration studies. MHS was used for binding to growth factors to stabilize 
them within OMA. The tested growth factors all have sites that natural bind to heparin 
sulfate which is to allow for a slower release of growth factors from the hydrogel 
[83,130,217-219]. Ultimately, we found that MHS does stabilize growth factor in OMA 
after an initial quick leach in the first 24 hours with an extended linear leach after that time, 
while VEGF in the absence of heparin sulfate also had a much faster immediate leach and 
was fully leached within four days. While many of release studies done on growth factor- 
heparin binding are conducted directly on the surface of materials, growth factors have 
more ways to escape the matrix in the 384-pillar plate with sidewalls. This potentially had
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an impact on the growth factor leaching, which may have also been exacerbated given the 
small area for polymerization and migration, producing an initially very fast first leach. In
the case of the heparin-bound samples, we believe the initial release growth factor is from 
unbound VEGF. Jeon et al have demonstrated the use of these growth factors at lower 
concentrations, producing linear release profiles [220]. This means that the growth factor 
concentration relative to the heparin sulfate may be high, producing the quick release seen 
in the first 24 hours for both samples. Strong initial release kinetics of heparin-bound 
VEGF have been observed previously, though it tends to have a linear release profile after 
the first day following our MHS model [216,220]. One other thing to note is that heparin 
sulfate binding and release kinetics can vary between growth factors, so it is quite possible 
more or less growth factor is released when using other growth factors [220-222]. This 
may produce different release profiles, though this behavior is expected to also be gradual 
if binding is successful. While there is still leaching of growth factors in the presence of 
MHS, ultimately the concentration of leached growth factors in media is still significantly 
less than the growth factor concentration in the printed OMA layer.
One of the major factors that also plays a role in migration and tumorgenesis is the 
role of O2 diffusion within the tumor. As hypoxia is common in larger tumors, cells in parts 
of the tumor are necrotic, while others begin moving in search of more nutrients, and O2 in 
particular. The transcription factor hypoxia-inducible factor 1-alpha (HIF-lα) which is 
downregulated by the presence of O2 is known to cause the expression of various proteins 
that signal for angiogenesis and proliferation, specifically upregulating both VEGF and 
TGFβl in vivo [223]. Additionally, HIF-lα is tied to the expression of metastatic and 
invasion cues, including several matrix metalloproteases (MMPs) and the c-Met
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[6,223,224]. With the formation of cancer spheroids within our system, the growth factors 
we supplemented are also secreted within the spheroids themselves, which can further 
enhance growth or migration.
We have successfully shown that several of our growth factors can trigger the 
expansion of Hep3B cells into spheroid structures. Some of these growth factors like HGF 
[225,226] and bFGF [83] are known to initiate cell growth independent of the status of the 
cancer. What was interesting was that growth was greatest in the presence of HGF more 
than other growth factors or the combination of growth factors. It is known that Hep3B 
cells do proliferate in response to stellate cells secretion of HGF [226]. This is likely due 
to the fact the HGF is secreted by stem cells in the liver to assist in wound healing. While 
it is unknown if Hep3B functions in the stem-cell like nature of cancer cells, it is known
that all of these growth factors can induce the proliferation of hepatic cells, including 
several known cancer cell lines. Hep3B in particular is known to express high-levels of 
FGF receptor II (FGFRII), which binds to bFGF [227]. Comparatively, Hep3B cells also 
secrete higher levels of TGFβl, which may also explain why they too experienced 
increased proliferation in the presence of this growth factor [227]. Since spheroid formation 
can occur independent the presence of growth factors (though it is enhanced by certain 
growth factors), it is important to eventually quantify the growth factors that are secreted 
instead of delivered. Subsequent growth factor quantification for intracellular production 
of growth factors can be performed looking at the genetic expression of the growth factors 
within the cell or performing western blot analysis on isolated cell samples.
Our results showed a mixed amount of migration, that was growth-factor dependent 
Specifically, bFGF and VEGF (and, to a lesser extent, TGFβl) seemed to stimulate
102
migration, while HGF did not generate much cellular movement. This is likely due to 
bFGF’s, TGFβl,s and VEGF’s roles in angiogenesis [28,209] and HGF’s role in 
proliferation [226]. While spheroid formation did occur in all conditions, spheroid
formation seemed to be contained to the second printed layer and individual cells migrated 
to the first printed layer as observed by the fact that spheroids did not exist near the pillar 
surface where the growth factors were printed. We believe this is due to the fact that while 
angiogenic growth factors seem to play a role in inducing migration, the growth factors 
that play a role in cell proliferation will not impact migration. Individual cells, particularly
ones searching for nutrients, are able to move through the matrix, while the tumors
themselves are static within the culture.
Another interesting result is that the combination of growth factors experiment 
yielded more migration than the control, but less than VEGF experiments, and how 
proliferation seemed to increase in the combination growth factor experiment relative to 
the control but was less than the HGF and TGFβl cases by day ten. We believe this is due 
to the limitation of room for heparin to bind growth factors. Thus, the combination 
experiment likely had less growth factor bound long term as all four growth factors were 
competing for the same space, which resulted in a response that trends towards the presence 
of individual growth factors but is somewhat muted because there are less overall.
4.5. Conclusions
We successfully developed a high-throughput 3D cell migration assay on a platform 
compatible with 384-well plates. The migration assay was able to quantify relative rates of 
migration in real-time for up to two weeks after initial seeding. We were also able to
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quantify proliferation rates of Hep3B cells in the presence of various growth factors. Our 
results reflected in literature that growth factors that promote angiogenesis also induce 
HCC migration and metastasis. Subsequent studies will look into comparing Hep3B cells 
with other cell lines so as to use this platform as a potential diagnostic marker for HCC. 
We also hope to look at different combinations of growth factors and ECM components as 
chemoattractants for cell migration and incorporate fibroblasts for co-culture to study the 
effects of restructuring of the ECM during angiogenesis and metastasis of HCC.
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CHAPTER V
CONCLUSIONS AND FUTURE DIRECTIONS
5.1. Conclusions
There is a recent shift in the development of in vitro cell cultures for modeling liver
disease from using 2D cultures to 3D cultures. This shift reflects the desires of individuals 
from academia and industry to have a model that reflects the in vivo behavior. These models 
can be of use in drug development for toxicity and efficacy studies, or as diagnostic and 
treatment tools as well. This thesis details methods for creating 3D liver cultures and assays 
for use in better understanding liver diseases, specifically focusing on HCC and ADRs. In 
this study, we have successfully used and optimized three different platforms and two 
hydrogels for the culture of Hep3B cells in 3D. We have also demonstrated how viral 
transductions can be used to code for various fluorescent proteins. Furthermore, we showed 
how we can use Hep3B cells transfected with lentiviruses can be tracked for a high- 
throughput 3D cell migration and invasion assay, and that this assay can be successfully 
conducted for up to two weeks after initial seeding.
The work presented here has several implications for industrial, pre-clinical, and 
academic use. The surface modification techniques discussed in aims 1 and 2 give
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researchers methods for immobilizing hydrogels onto polystyrene surfaces. In addition, 
these modifications are suitable hydrogel-based microarray technologies, as our group has 
subsequently used both PMA-OD and plasma treatment to immobilize other hydrogels 
onto the surfaces of our polystyrene-based microarray platforms. In aims 1 and 3, we 
successfully transduced viruses into cells containing the expression of fluorescent proteins. 
In the case of PuraMatrix, this transduction means that encapsulated cells may be 
transduced with adenoviruses in situ, allowing for scientists to modify the genetic 
expression within encapsulated cells. This allows researchers to study various disease 
states, including genetic polymorphisms that may affect DILI or HCC. DILI is a likely 
candidate for future studies as cells encapsulated in PuraMatrix exhibited dose-dependent 
responses to several tested toxic compounds. The transduction performed using 
lentiviruses on Hep3B cells created a permanently fluorescent cell line that could be used 
to track cell growth and movement in vitro. We optimized the polymerization parameters 
for two hydrogels for microscale tissue culture, which allows for both of these hydrogels 
to be used in other small-scale tissue cultures. Finally, aim 3 also saw the development of 
a high-throughput, quantitative 3D cell migration assay. The techniques developed in the 
third aim can be applied for monitoring multiple cell types if different cell types contain 
individual fluorescent tags, meaning that more complex tissue models can be studied. 
While this assay was designed with HCC in mind, other types of cancer or any mammalian 
cells that respond to the presence of growth factors can also be assessed. Table 7 presents 
the key findings of these studies.
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Table 7. Summary of Results from Individual Aims
Aim 1 Aim 2 Aim 3
Encapsulate hepatic cells in 
hydrogels that can be used 
for high-throughput drug
screening and in situ 
adenoviral transduction
Optimize hepatic cell 
encapsulation conditions in 
a photopolymerizable 
hydrogel for creating 
layered cell structures
Simulate migration of liver 
cancer cells in 3D and 
quantify their migration in 
situ in high throughput
• Provided robust spot • Optimized surface plasma • Created a macro that can
attachment between treatment of microwell quantify cell migration in
hydrogels and micropillar chips 3D
chips • Found optimal • Transduced lentiviruses
• Optimized parameters for OMA into Hep3B cells
polymerization of polymerization based on containing expression for
PuraMatrix on the background color, PI mCherry
micropillar chip concentration, OMA • Demonstrated stability of
• Transduced adenoviruses concentration, light MHS-bound growth
into encapsulated Hep3B intensity/duration, and factors in OMA for two-
cells methacrylation week long leaching.
• Demonstrated dose- percentage • Proliferated encapsulated
response behavior of Hep3B cells for two
encapsulated cells weeks after seeding
• Demonstrated migration
of Hep3B cells in
response to angiogenic
factors
5.2. Future Directions and Recommendations
1) Cells encapsulated in PuraMatrix are susceptible to toxicity due to the handling of the 
cells before printing and the rather low pH of the hydrogel before the washing steps. Other 
cell lines may be less susceptible to the toxic effects of this hydrogel. Additionally, as 
demonstrated within the first aim, Hep3B cells can be transduced with adenoviruses in situ. 
Future experiments can focus on transductions carrying genes coding for various DMEs
with a focus on DILI.
2) Temperature is a major factor when controlling for toxicity associated with OMA 
polymerization. This is the reason why gelation and viability were optimized on a narrow
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range of conditions. If the height of the lamp above the exposed surface is changed, 
remember to also change the exposure intensity accordingly.
3) The roughness of the surface increases the duration of plasma treatment necessary to 
prevent bubble formation. Smoother polystyrene surfaces can be plasma exposed for as 
little as five minutes to ensure proper functionalization. All of our scaffolds are generally 
considered to not be smooth, but other microarray technologies may be different.
4) While we demonstrated the migration potential of Hep3B cells, we did not compare 
these results to other HCC cells lines, patient samples, other kinds of cancer, or other cells 
that are known to move in response to various cues. As a potential diagnostic assay, future 
studies should focus on comparing migration potential of Hep3B cells against other known 
tumor cell lines and explanted tumor tissue and using other chemorepellants and 
chemoattractants to induce migration.
5) Our current system does not account for growth factor generation during cancer cell 
proliferation, and there is no discussion of understanding the role of O2 transport in the 
behavior of cells within the spheroids. To fully understand these phenomena, it is necessary 
to model transport of growth factors and O2 within the spheroid, and possibly monitor 
expression of HIF-lα or try to stain hypoxic regions within the samples.
6) Our platform is ideally suited for combinatorial studies, yet most of the experiments 
were performed with high numbers of replicates with few combinatorial studies done to 
limit error. Work on the micropillar chip does not focus on the impacts of multiple drugs 
within a system, and the work on the 384-pillar plate with sidewalls uses only one or four 
combinations of growth factors to study migration. Additionally, growth factor 
concentration was fixed for the study.
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7) ECM components were not incorporated as another mechanism that could impact cell 
proliferation and migration, which is especially important in the tumor microenvironment.
8) The cancer microenvironment consists of several different cell types, so the current 
model is rather simplistic from a biological perspective. Future experiments will focus on 
the use co-cultures of fibroblasts and HCC cells to model the restructuring of the tumor 
during angiogenesis. If these experiments are successful, we may incorporate some cells 
of the immune system as well.
9) As use of the 384-pillar plate with side walls was suitable for fourteen days of cell culture, 
we hope to expand the time used in the culture to longer periods. Furthermore, we hope to 
use the system to model the behavior of cells in liver co-cultures and look into organoid 
development on this platform to study liver biology and other liver diseases.
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A. 1. OMA-15 Viability and Polymerization Results
Table 7 Lists all of the various experiments performed on using OMA-15 as a 
scaffold for growing Hep3B cells. All experiments were performed with the same 
optimized plasma surface treatment of high RF exposure for 15 minutes. In general, OMA- 
15 proved to be an unsuitable scaffold at the conditions we tested. While viable cells were 
achieved at several of the listed conditions, polymerization was not observed in an of the 
indicated conditions. Ultimately, unpolymerized hydrogels resulted in cell settling at the 
bottom of the microwell chip forming 2D confluent layers if toxicity was not observed.
Table 8. Photopolymerization tested on OMA-15
Concentration
(w/v %)
Exposure 
Intensity (%)
Exposure 
Time (min)
PI
(w/v %)
Viable
Cells?
Gel
formed?
4,8
0.1, 0.2, 
0.3 No No
4 45 0.3, 0.4, 0.5 No No
3,6 0.025, 0.05, 0.1 Yes No
2 45 3,6 0.1, 0.2, 0.3 No No
2
70 0.5, 1 0.025, No No
4
0.05, 0.1
2
70 0.75, 1.5 (immersion)
0.025, Yes No
4
0.05, 0.1
2
70 1,2(immersion)
0.025, 
0.05, 0.1
Yes(l
min) No
4
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An additional experiment we performed was testing how immersion of our samples 
in water could affect polymerization. Our reasoning was that increased temperatures due 
to the intensity of exposed light can warm the sample sufficiently enough to either damage 
the cells or make them more susceptible to oxidative stress. Samples that were immersed 
in water had a breath-easy membrane added to the surface after printing but before 
exposure. Ultimately, the results had no effect on increasing polymerization efficiently 
though viable 2D cells were achieved during shorter durations.
A.2. Photopolymerizable Collagen Results
We attempted to work with a commercialized variation of methacrylated collagen. 
Since much of the liver ECM scaffold consists of collagen I, we thought using a 
photopolymerizable variant would yield an optimized biocompatibility while give us 
control over when gelation occurs. Moreover, photocrosslinking would increase robustness 
of a hydrogel that polymerizes due to increases in temperature. Cells would be printed at 4 
* 106 cells/mL into microwell chips, with collagen concentration varying between 1 and 3 
mg∕mL, and PI concentration at 0.05 w/v % (using Irgacure 2959). Before adding cells, 
collagen must be suspended in 20 mM acetic acid and then neutralized with the requisite 
neutralization solution provided by Advanced BioMatrix (52O1-1EA). 
Photopolymerization occurred at 4 mW∕cm2 for 30 seconds, followed by incubating 
microwell chips at 370C for half an hour in a moisture-controlled chamber before being 
immersed into complete RPMI in petri plates.
The results of the experiment are shown in Figure 18. Polymerization of collagen
was successful at 2 and 3 mg∕mL, while using 1 mg/mL produced confluent cells. The use
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of PI had a toxic effect at all indicated concentrations. The results indicate that at our tested
values, while collagen is a suitable hydrogel, adding the photocrosslinking step does not 
improve the robustness of the hydrogel at any concentrations and impacts viability 
throughout. Like 0MA-15, we discarded use of this hydrogel after several attempts to 
decrease the toxicity associated with photopolymerization while varying polymerization 
parameters. It is possible that this hydrogel is
A.3. pcDNA Transfections into Hep3B cells.
As an alternative method to create a permanently fluorescent cell line, we attempted 
to transfect plasmid DNA into Hep3B cells. We used a Lipofectamine 2000 Transfection 
Kit (Thermofisher scientific, catalog no. 11668027) with high concentrations of pcDNA 
(500-5000 ng∕mL) containing the expression of RFP. After leaving the transfection
reagents on for 48 hours, we attempted to select out cells using genticin with variable 
concentration (1-10%). Our results were ultimately unsuccessful. While transfection was 
successful, Hep3B cells proved not to be susceptible to genticin toxicity, meaning we could 
not select out cells that were not transfected. While this method could be potentially used 
for other cell lines, it is not compatible with Hep3B cells.
A.4. Assessing Fluorescent Reagents for CYP450 Activity
Several fluorescent and one luminescent assay was conducted to work with 
CYP450 enzymes (table 9). These substrates were tested for activity according to 
manufacturer’s protoctols against pure enzymes, against cells infected with adenoviruses 
containing the expressions of these enzymes, and cDNA/pcDNA transfected cells. With 
the exceptions of 7-EC and MFC, all substrates fluoresced/luminesced when tested against 
their specific enzymes. However, only EOMCC/BOMCC worked against virus infected
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cells. This indicates that these substrates are the only ones that can be use of the tested 
enzymes for cell-based activity. Furthermore, only CYP1A2 and CYP2C9 expression was 
successfully transduced into Hep3B cells.
Table 9. Substrates tested for CYP450 activity
Substrate Metabolite Isoform Enzyme
Activity
Virus
Activity
7-Ethoxycoumarin (7-EC) 7-Hydroxycoumarin 1A2 - -
Dibenzyl-fluorescein (DBF) Fluorescein 2C9 + -
3-[2-(N,N-diethyl-N- 
methyl-ammonium)ethy1]-7- 
methoxy-4-methylcoumarin 
(AMMC) Iodide
3-[2-(N,N-diethyl-N-
methyl-
ammonium)ethy1] -Ί- 
hydroxy-4- 
methylcoumarin 
(AHMC) Iodide
2D6 +
7-Methoxy-4-
Trifluoromethylcoumarin
(MFC)
7-hydroxy-4- 
Trifluoromethylcoum 
arin (HFC)
2E1
7-benzyloxy-4-
Trifluoromethylcoumarin
(BFC)
HFC 3A4 +
7-ethyloxymethyloxy-3- 
cyanocoumarian (EOMCC)
7-hydroxy-3-
cyanocoumarin
1A2/2D
6/2E1
++/+∕+ +/-∕-
7-benzyloxymethyloxy-3- 
cyanocoumarian (BOMCC)
7-hydroxy-3-
cyanocoumarin
2C9/3A
4
+/++ +/-
Luciferin-
pentafluorobenzene
(Luciferin-PFBE)
Luciferin 3A4 +
(-) No activity detected. (+) Moderate response. (++) significant response.
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